Next Article in Journal
A Subtraction-Average-Based Optimizer for Solving Engineering Problems with Applications on TCSC Allocation in Power Systems
Previous Article in Journal
Recent Advances in the Production of Pharmaceuticals Using Selective Laser Sintering
Previous Article in Special Issue
Biomimetic Enamel Regeneration Using Self-Assembling Peptide P11-4
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Improving Oral Health with Fluoride-Free Calcium-Phosphate-Based Biomimetic Toothpastes: An Update of the Clinical Evidence

1
Faculty of Dentistry, University of Toronto, Toronto, ON M5G 1G6, Canada
2
Dr. Kurt Wolff GmbH & Co. KG, Research Department, Johanneswerkstr. 34-36, 33611 Bielefeld, Germany
*
Author to whom correspondence should be addressed.
Biomimetics 2023, 8(4), 331; https://doi.org/10.3390/biomimetics8040331
Submission received: 22 June 2023 / Revised: 13 July 2023 / Accepted: 25 July 2023 / Published: 27 July 2023
(This article belongs to the Special Issue Biomimetic Remineralization on Enamel and Dentin)

Abstract

:
As the demand for clinically effective fluoride-free oral care products for consumers increases, it is important to document which types of toothpastes have been shown in clinical studies to be effective in improving oral health. In this review, we included different indications, i.e., caries prevention, improving periodontal health, reducing dentin hypersensitivity, protecting against dental erosion, and safely improving tooth whitening in defining what constitutes improvement in oral health. While there are several professional and consumer fluoride-containing formulations fortified with calcium-phosphate-based ingredients, this review focuses on fluoride-free toothpastes containing biomimetic calcium-phosphate-based molecules as the primary active ingredients. Several databases were searched, and only clinical trials in human subjects were included; in vitro and animal studies were excluded. There were 62 oral health clinical trials on biomimetic hydroxyapatite (HAP), 57 on casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), 26 on calcium sodium phosphosilicate (CSPS, or so called Bioglass), and 2 on β-tricalcium phosphate (β-TCP). HAP formulations were tested the most in clinical trials for benefits in preventing caries, dentin hypersensitivity, improving periodontal health, and tooth whitening. Based on the current clinical evidence to date, fluoride-free HAP toothpaste formulations are the most versatile of the calcium phosphate active ingredients in toothpastes for improving oral health.

1. Introduction

Even in the 21st century, poor oral health remains a major human affliction burdening health care systems in countries all over the world. Dental decay (caries) is still the most common affliction of children and very common in adults [1]. Periodontal disease today is the main reason for tooth loss throughout industrialized countries [2]. However, these human afflictions are preventable with improved diets, healthy nutrition, and especially with improved oral hygiene using toothpastes with active ingredients designed to prevent these common health issues [3]. Furthermore, as teeth are expected to last for a lifetime in ageing populations, dental tissues need to be protected from dental erosion. Some oral care products help protect teeth from mineral loss improving the longevity of the dentition [4]. In addition, people today want whiter and healthier looking teeth. Adults value the cosmetic appearance of their teeth; a whiter dentition improves confidence, improves social acceptance and even employment prospects [5]. Therefore, there is a need to develop active ingredients for toothpastes designed to help with one or more of the preventive roles in home oral care.
Fluoride has been the active ingredient most used in toothpastes throughout the world for the prevention of dental caries for a long time. That fluoride toothpaste reduces dental decay has been documented with many placebo-controlled clinical trials [6]. In order to improve fluoride toothpaste formulations to also help prevent gingivitis and lower the risk of periodontal disease, additional ingredients are added. These include pyrophosphates to help reduce calculus formation [7], bicarbonate for dental plaque removal [8], as well as antibacterial agents such as stannous salts [9], zinc salts [10], and chlorhexidine at low concentrations [11]. Natural ingredients such as herbs and plant-based antimicrobials have also been tested mostly in non-fluoride toothpastes [12].
Fluoridated toothpastes pose safety issues for children under age 6 since there is risk of dental fluorosis from fluoride ingestion [13]. Children under age 3 swallow a significant amount of toothpaste even if they are able to rinse and spit [14]. Because of the risk of fluoride ingestion, dentists in the US and Canada are advised to recommend families with children under the age of 3 year to use a pea-sized amount of fluoridated toothpaste [15,16]. In Europe, children up to age 2 should use a rice-size smear, and those aged 2 to 6 years, a pea size amount [17]. However, children, but also their parents when applying toothpaste for their children, still tend to use more toothpaste, and the majority of those ages ≤ 3 years use it 2 times a day or more often [18]. There is no direct evidence that these smaller amounts of toothpaste can prevent cavities [19]. One study showed that the pea-size amount is less effective in cleaning teeth compared to larger toothpaste amounts [20]. Recent concerns about fluoride’s potential neurotoxicity on developing brains [21,22] have also spurred on research to find alternatives to fluoride as an active ingredient in toothpastes. There is now a concerted effort to find effective non-fluoride anti-caries agents. However, because there is also the need to improve general oral health by also reducing the risk of gingivitis, reducing dentin sensitivity, preventing dental mineral loss, and improving on the appearance of teeth, the active ingredient needs to be very versatile and provide more than one benefit. One ingredient, hydroxyapatite (HAP), has been tested clinically as a general multifunctional useful active ingredient [23].
The most promising candidate active ingredients in toothpastes for achieving all these goals in the future are the calcium-phosphate-based molecules [24]. There is a wide range of these inorganic molecules and the most researched ingredients in this class that have already been tested in toothpastes are amorphous calcium derivatives (casein phosphoprotein-amorphous calcium phosphate, or CPP-ACP), hydroxyapatite, calcium sodium phosphosilicate (CSPS, Novamin, Bioglass), and beta-tricalcium phosphate (β-TCP). A recent review on randomized clinical trials comparing calcium-phosphate-based ingredients was published [25], but the authors omitted clinical evidence from in situ trials, where active ingredients are applied to human enamel slabs imbedded in appliances worn by volunteer subjects. Additionally, the authors did not examine the clinical evidence for hydroxyapatite’s usefulness in controlling caries, even though it has been shown to clinically produce calcium phosphate ions required for remineralization and there have been clinical trials published to show reversal of carious lesions [26].
This review was conducted to examine the clinical evidence published for fluoride-free calcium-phosphate-based toothpastes in order to compare them for determining which one might be a versatile, overall effective toothpaste formulation in promoting good overall oral health.

2. Materials and Methods

A PICO framework was used to guide the search. The following question was posed: “Do fluoride-free toothpastes containing calcium-phosphate-based active ingredients help to improve oral health”? The target populations (P) were humans of all ages. The intervention (I) was using one of the following calcium-phosphate-based active ingredients in a human subject clinical trial, including in situ trials using human enamel imbedded in intra-oral appliances worn by human subjects: amorphous calcium derivatives (casein phosphoprotein-amorphous calcium phosphate, or CPP-ACP), hydroxyapatite (HAP), calcium sodium phosphosilicate, (CSPS, Bioglass) and beta-tricalcium phosphate (β-TCP). The controls (C) were untreated teeth or placebo toothpastes, or positive control toothpastes, and the outcome (O) was one of the following: lowered caries or reduction in white spot lesions, reduced dentin hypersensitivity, protection against dental erosion, improvement of gingival or periodontal health, and/or improved appearance of teeth. The literature was searched using the University of Toronto databases PubMed (Medline), Scopus, and Web of Science, as well as Google Scholar, from inception to 1 June 2023. For the active ingredients, the search terms were “hydroxyapatite”, or “nano-hydroxyapatite”; “casein phosphopeptide-amorphous calcium phosphate” or “CPP-ACP”, or “amorphous calcium phosphate” or “ACP”; “calcium sodium phosphosilicate” or “CSPS” or “bioglass” or “novamin”; “beta-tricalcium phosphate” or “β-TCP” or “tricalcium phosphate” or “TCP”. For the vehicle, the search terms were “toothpaste” or “dentifrice”. For the experimental conditions, the search terms were “in vivo”; ”in situ”; “clinical trial”. For the remineralization outcomes, the search terms were “caries” or “white spot lesion” or “WSL”; “remineralization”; “erosion”. For the dentin hypersensitivity outcomes, they were “sensitivity” or “hypersensitivity”. For the gingival health outcomes, the search terms were “gingivitis” or “gingival” or “periodontal” or “periodontitis”. For the tooth whitening outcomes, the search words were “whiten(s)” or “whitening”.
Inclusion and exclusion criteria: The selection of studies was based on the need to focus on only clinical trials that produced direct clinical evidence for the outcomes directly related to oral health improvement. Animal and in vitro studies were excluded, even those that provide support for the mechanisms of how the active ingredients provide benefits since the evidence needs to be gathered from clinical trials in human subjects. In situ studies were included if the enamel slabs imbedded in appliances worn by volunteer subjects were derived from human (not bovine) enamel. In vivo effects on Streptococcus mutans and intra-oral mineral release studies were excluded. All reviews, abstracts, and book chapters were excluded. There were no language restrictions.
Microsoft Excel spreadsheets of the publications were produced by manually downloading the particulars of each publication of interest (authors, title, journal, abstract, key words) or converting “cvs” files generated by the databases, such as Scopus. The studies were ordered alphabetically, and duplicates were manually removed. Even though the collection of papers was obtained systematically, qualitative syntheses (risk of bias) and quantitative syntheses (meta-analysis) were not carried out. Qualitative (risk of bias) and quantitative (meta-analyses) have been conducted elsewhere on hydroxyapatite-containing oral care products [5,26,27], so the aim of this review was to systematically document the studies published for other fluoride-free calcium phosphate toothpastes, in comparison to the current literature on hydroxyapatite toothpastes, in order to determine the volume and extent of this evidence. Qualitative and quantitative meta-analysis of that literature was not the focus of this review.

3. Results

The results of the search are shown in Figure 1.
A total of 144 clinical trials and in situ clinical studies resulted after applying the exclusion and inclusion criteria. The majority (>80%) of the clinical studies were conducted on HAP- and CPP-ACP-containing toothpastes. Clinical studies on CSPS were mostly on dentin hypersensitivity (DH), and there were only two clinical trials found testing fluoride-free TCP toothpaste. With so many search term combinations, the Google Scholar search yielded an imprecise and excessively large number of titles which, after rapid screening, contained many citations, duplicates, and irrelevant publications. The focus was, therefore, on the titles retrieved in the PubMed, Scopus, and Web of Science databases. Both Scopus and Web of Science permitted “search within results” where subsets of publications were obtained from the large list of publications found using the starting primary search word (e.g., “hydroxyapatite”).
Table S1 shows the distribution of the clinical studies found using the main databases as a result of the various combinations of search terms. The publications that were retrieved in full and carefully read for each of the calcium-phosphate-based toothpaste active ingredients are summarized in Table 1, Table 2, Table 3 and Table 4. Some studies were cited more than once in the tables because they examined more than one aspect of improving oral health in the same study.

3.1. Hydroxyapatite (HAP)

The authors of this review have previously published systematic reviews of the clinical evidence that HAP reduces dental caries [26], reduces dentin hypsersenstivity [27], and improves tooth color [5]. That literature has been updated in this review to include the most recent publications. A total of 62 clinical trials were found where HAP toothpaste was shown to reduce caries, remineralize enamel and protect against erosion, reduce dentin hypesensitivity, improve tooth color, and support gingival health (Table 1).

3.2. Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP)

A total of 57 clinical trials were found on CPP-ACP toothpaste showing that this form of calcium-phosphate-based toothpaste reverses white spot lesions, protects against dental erosion and reduces dentin hypersensitivity (Table 2). Only one study was found where CPP-ACP toothpaste was tested to improve gingival health. Several studies were found to show that CPP-ACP reduced dentin hypersensitivity in studies measuring the effectiveness of professional peroxide bleaching products and that the CPP-ACP did not interfere with the whitening process, but none were found where the active ingredient CPP-ACP was tested on its own in a toothpaste for whitening teeth.

3.3. Calcium Sodium Phosphosilicate (CSPS, Novamin, Biomin, Bioglass)

There have been several studies on fluoride toothpastes fortified with Novamin (CSPS), but those were not summarized in this review since the focus was on fluoride-free toothpastes. Recently, two studies examined CSPS as an active ingredient in fluoride-free toothpastes for controlling caries or white spot lesions [122,145]. There were 23 clinical studies found showing that CSPS was also capable of reducing dentin hypersensitivity. One study was found where CSPS as an isolated active ingredient was able to control gingival health. No studies were found where CSPS toothpastes were tested to improve the color of teeth. These studies are summarized in Table 3.

3.4. Beta-Tricalcium Phosphate (β-TCP)

The clinical literature on tricalcium phosphate toothpaste in improving oral health was very limited. While there were a number of in vitro studies and studies conducted on fluoride toothpaste with added TCP (called ‘functionalized’ TCP), only one clinical trial was found where a fluoride-free TCP toothpaste was tested in a clinical trial for reducing caries, and one clinical trial examined how fluorid-free TCP in toothpaste affected dentin hypersensitivity (Table 4).

4. Discussion

This systematic review was conducted to compare the clinical evidence that has been published on the calcium-phosphate-containing toothpastes designed to improve oral health. We were interested in comparing the calcium-phosphate-based active ingredients without fluoride. Many fluoride toothpaste formulations contain calcium phosphate additives in an attempt to improve the remineralization and protection of tooth enamel, but recent studies have shown that some ingredients, such as hydroxyapatite, perform as well if not better than fluoridated toothpaste [24,26,27]. Dental fluorosis has been an increasing concern, particularly in those countries that continue to fluoridate their drinking water supplies [169]. In addition, there are concerns that prenatal and even postnatal exposure to fluoride is linked to interference with brain function during early development and growth [170]. For these reasons, it is worthwhile to seek alternatives to fluoridated toothpaste.
The fluoride-free, calcium-phosphate-containing toothpaste formulations tested in the studies summarized in this review show great promise in that they have been shown in clinical trials to prevent dental decay, reverse white spot lesions, remineralize tooth enamel, protecting it from erosion, desensitize hypersensitive root surfaces and even improve gingival health, all while whitening and brightening the dentition.
There were 62 clinical studies found where HAP was the active ingredient and almost an equal number of clinical studies conducted on CPP-ACP. The vast majority of them used fluoride-toothpaste as positive controls. No study was conducted to compare HAP vs. CPP-ACP in a head-to-head clinical trial. Toothpastes containing CPP-ACP, which contains casein peptides, cannot be used in patients who are allergic to milk proteins. Neither can that toothpaste be given a ‘vegan’ designation. Calcium phosphate ingredients, if accidentally swallowed, are considered safe since they dissociate in the stomach into their constituent inorganic components (calcium and phosphate ions), which are not only harmless but actually contribute to needed dietary sources [171].
One other fluoride-free calcium-phosphate active ingredient that should have been considered but not included in the search was calcium glycerophosphate (CaGP), an active ingredient mentioned in the review by Enax et al. [172] on the remineralization strategies of molar incisor hypocalcification. While this ingredient is used mainly to fortify fluoride toothpaste, it has only been tested in three clinical trials as an active ingredient without fluoride [173,174,175]. In those recent trials, it has been shown to be effective on its own and should really be counted as the fifth active ingredient for fluoride-free calcium-phosphate-containing toothpaste with the potential to reverse white spot lesions.

5. Future Directions

While the clinical evidence to date on the effectiveness of biomimetic fluoride-free calcium-phosphate ingredients in oral care products is already quite extensive and based on dozens of clinical trials, the development of new strategies and products for the prevention and control of oral diseases and maintaining good oral health should continue. Randomized clinical trials (RCTs) where calcium-phosphate-based toothpaste formulations are tested in head-to-head experiments have not been conducted. These would be useful in order to determine which active ingredients most meet the needs of the average consumer in improving overall oral health. Additional clinical trials are required using subjects in susceptible populations and in all age groups.

6. Conclusions

Because of the concern by families of the lasting negative effects of fluoride ingestion with the use of fluoridated toothpaste, there is increased interest by researchers in preventive dentistry to clinically test fluoride-free toothpastes for the potential to be effective in improving oral health. While there is extensive clinical evidence that the biomimetic approach of using hydroxyapatite, casein phopshopeptide-amorphous calcium phosphate, or calcium sodium phosphosilicate has proven successful, additional clinical studies would help identify the most effective active ingredients so that dentists can tailor targeted preventive regimens best suited for patients’ needs. Based on the current clinical evidence to date, fluoride-free hydroxyapatite seems to be an all-round, versatile, and effective agent for improving oral health, in comparison to the other calcium phosphate active ingredients in toothpastes tested clinically.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/biomimetics8040331/s1, Table S1: Search results using designated search terms.

Author Contributions

Conceptualization, H.L., F.M. and J.E.; literature search, H.L., F.M. and J.E.; qualitative synthesis and writing, H.L.; review and editing, F.M. and J.E.; supervision, final editing, corresponding author, H.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data used in this review was published data in the studies referenced. Online information was referenced and accessed as shown in the reference list. No new data were created.

Conflicts of Interest

J.E. and F.M. are senior scientists and employees of Dr. Kurt Wolff GmbH & Co. KG in Germany.

References

  1. Meyer, F.; Enax, J. Early childhood caries: Epidemiology, aetiology, and prevention. Int. J. Dent. 2018, 2018, 1415873. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Kwon, T.; Lamster, I.B.; Levin, L. Current Concepts in the Management of Periodontitis. Int. Dent. J. 2021, 71, 462–476. [Google Scholar] [CrossRef] [PubMed]
  3. Fraihat, N.; Madae’en, S.; Bencze, Z.; Herczeg, A.; Varga, O. Clinical Effectiveness and Cost-Effectiveness of Oral-Health Promotion in Dental Caries Prevention among Children: Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2019, 16, 2668. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Zanatta, R.F.; Caneppele, T.M.F.; Scaramucci, T.; El Dib, R.; Maia, L.C.; Ferreira, D.M.T.P.; Borges, A.B. Protective effect of fluorides on erosion and erosion/abrasion in enamel: A systematic review and meta-analysis of randomized in situ trials. Arch. Oral Biol. 2020, 120, 104945. [Google Scholar] [CrossRef]
  5. Limeback, H.; Meyer, F.; Enax, J. Tooth Whitening with Hydroxyapatite: A Systematic Review. Dent. J. 2023, 11, 50. [Google Scholar] [CrossRef]
  6. Walsh, T.; Worthington, H.V.; Glenny, A.M.; Marinho, V.C.; Jeroncic, A. Fluoride toothpastes of different concentrations for preventing dental caries. Cochrane Database Syst. Rev. 2019, 3, CD007868. [Google Scholar] [CrossRef]
  7. Hong, I.; Lee, H.G.; Keum, H.L.; Kim, M.J.; Jung, U.W.; Kim, K.; Kim, S.Y.; Park, T.; Kim, H.J.; Kim, J.J.; et al. Clinical and Microbiological Efficacy of Pyrophosphate Containing Toothpaste: A Double-Blinded Placebo-Controlled Randomized Clinical Trial. Microorganisms 2020, 8, 1806. [Google Scholar] [CrossRef]
  8. Taschieri, S.; Tumedei, M.; Francetti, L.; Corbella, S.; Del Fabbro, M. Efficacy of 67% sodium bicarbonate toothpaste for plaque control and gingivitis control. A systematic review and meta-analysis. J. Evid. Based Dent. Pract. 2022, 22, 101709. [Google Scholar] [CrossRef]
  9. Lorenz, K.; Hoffmann, T.; Heumann, C.; Noack, B. Effect of toothpaste containing amine fluoride and stannous chloride on the reduction of dental plaque and gingival inflammation. A randomized controlled 12-week home-use study. Int. J. Dent. Hyg. 2019, 17, 237–243. [Google Scholar] [CrossRef]
  10. Prasad, K.V.; Therathil, S.G.; Agnihotri, A.; Sreenivasan, P.K.; Mateo, L.R.; Cummins, D. The Effects of Two New Dual Zinc plus Arginine Dentifrices in Reducing Oral Bacteria in Multiple Locations in the Mouth: 12-Hour Whole Mouth Antibacterial Protection for Whole Mouth Health. J. Clin. Dent. 2018, 29, A25–A32. [Google Scholar]
  11. Yates, R.; Jenkins, S.; Newcombe, R.; Wade, W.; Moran, J.; Addy, M. A 6-month home usage trial of a 1% chlorhexidine toothpaste (1). Effects on plaque, gingivitis, calculus and toothstaining. J. Clin. Periodontol. 1993, 20, 130–138. [Google Scholar] [CrossRef] [PubMed]
  12. Rajendiran, M.; Trivedi, H.M.; Chen, D.; Gajendrareddy, P.; Chen, L. Recent Development of Active Ingredients in Mouthwashes and Toothpastes for Periodontal Diseases. Molecules 2021, 26, 2001. [Google Scholar] [CrossRef]
  13. Santos, A.P.; Oliveira, B.H.; Nadanovsky, P. Effects of low and standard fluoride toothpastes on caries and fluorosis: Systematic review and meta-analysis. Caries Res. 2013, 47, 382–390. [Google Scholar] [CrossRef] [PubMed]
  14. van Loveren, C.; Ketley, C.E.; Cochran, J.; Duckworth, R.M.; O’Mullane, D.M. Fluoride ingestion from toothpaste: Fluoride recovered from the toothbrush, the expectorate and the after-brush rinses. Commun. Dent. Oral. Epid. 2004, 32 (Suppl. S1), 54–61. [Google Scholar] [CrossRef] [PubMed]
  15. American Dental Association Council on Scientific Affairs. Fluoride Toothpaste Use for Young Children. J. Am. Dent. Assoc. 2014, 145, 190–191. Available online: https://jada.ada.org/article/S0002-8177(14)60226-9/pdf (accessed on 4 May 2023).
  16. Canadian Dental Association. CDA Position on Fluoride. February 2021. Available online: https://www.cda-adc.ca/_files/position_statements/fluoride.pdf (accessed on 4 May 2023).
  17. Toumba, K.J.; Twetman, S.; Splieth, C.; van Loveren, C.; Lygidakis, N.A. Guidelines on the use of fluoride for caries prevention in children: And updated EAPD policy document. Eur. Arch. Paed. Dent. 2019, 20, 507–516. [Google Scholar] [CrossRef] [Green Version]
  18. Thornton-Evans, G.; Junger, M.L.; Lin, M.; Wei, L.; Espinosa, L.; Beltran-Aguilar, E. Use of toothpaste and toothbrushing among children and adolescents—United States, 2013–2016. MMWR Morb. Mortal. Wkly. Rep. 2019, 68, 87–90. [Google Scholar] [CrossRef] [Green Version]
  19. Creeth, J.; Bosma, M.L.; Govier, K. How much is a ‘pea-sized amount’? A study of dentifrice dosing by parents in three countries. Int. Dent. J. 2013, 63 (Suppl. S2), 25–30. [Google Scholar] [CrossRef]
  20. Sarembe, S.; Ufer, C.; Kiesow, A.; Limeback, H.; Meyer, F.; Fuhrmann, I.; Enax, J. Influence of the Amount of Toothpaste on Cleaning Efficacy: An In Vitro Study. Eur. J. Dent. 2022, 17, 497–503. [Google Scholar] [CrossRef]
  21. Till, C.; Green, R. Controversy: The evolving science of fluoride: When new evidence doesn’t conform with existing beliefs. Pediatr. Res. 2020, 90, 1093–1095. [Google Scholar]
  22. National Toxicology Program. NTP Board of Scientific Counselors Working Group Report on the Draft State of the Science Monograph and the Draft Meta-Analysis Manuscript on Fluoride. 2023. Available online: https://ntp.niehs.nih.gov/sites/default/files/2023-04/wgrptBSC20230400.pdf (accessed on 4 May 2023).
  23. Steinert, S.; Zwanzig, K.; Doenges, H.; Kuchenbecker, J.; Meyer, F.; Enax, J. Daily application of a toothpaste with biomimetic hydroxyapatite and its subjective impact on dentin hypersensitivity, tooth smoothness, tooth whitening, gum bleeding, and feeling of freshness. Biomimetics 2020, 5, 17. [Google Scholar] [CrossRef]
  24. Meyer, F.; Amaechi, B.T.; Fabritius, H.-O.; Enax, J. Overview of Calcium Phosphates in Biomimetic Oral Care. Open Dent. J. 2018, 12, 406–423. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Singal, K.; Sharda, S.; Gupta, A.; Malik, V.S.; Singh, M.; Chauhan, A.; Agarwal, A.; Pradhan, P.; Singh, M. Effectiveness-of Calcium Phosphate derivative agents on the prevention and remineralization of caries among children- A systematic review & meta-analysis of randomized controlled trials. J. Evid. Based Dent. Pract. 2022, 22, 101746. [Google Scholar] [PubMed]
  26. Limeback, H.; Enax, J.; Meyer, F. Biomimetic hydroxyapatite and caries prevention: A systematic review and meta-analysis. Can. J. Dent. Hyg. 2021, 55, 148–159. [Google Scholar] [PubMed]
  27. Limeback, H.; Enax, J.; Meyer, F. Clinical Evidence of Biomimetic Hydroxyapatite in Oral Care Products for Reducing Dentin Hypersensitivity: An Updated Systematic Review and Meta-Analysis. Biomimetics 2023, 8, 23. [Google Scholar] [CrossRef]
  28. Kani, K.; Kani, M.; Isozaki, A.; Shintani, H.; Ohashi, T.; Tokumoto, T. Effect of apatite-containing dentifrices on dental caries in school children. J. Dent. Health 1989, 19, 104–109. [Google Scholar] [CrossRef] [Green Version]
  29. Lelli, M.; Putignano, A.; Marchetti, M.; Foltran, I.; Mangani, F.; Procaccini, M.; Roveri, N.; Orsini, G. Remineralization and repair of enamel surface by biomimetic Zn-carbonate hydroxyapatite containing toothpaste: A comparative in vivo study. Front. Physiol. 2014, 5, 333. [Google Scholar] [CrossRef] [Green Version]
  30. Makeeva, I.M.; Polyakova, M.A.; Avdeenko, O.E.; Paramonov, Y.O.; Kondrati’ev, S.A.; Pilyagina, A.A. Evaluation of the effectiveness of long-term use of Apadent Total Care toothpaste containing medical nano-hydroxyapatite. Stomatologiia 2016, 95, 34–36. [Google Scholar] [CrossRef]
  31. Schlagenhauf, U.; Kunzelmann, K.H.; Hannig, C.; May, T.W.; Hösl, H.; Gratza, M.; Viergutz, G.; Nazet, M.; Schamberger, S.; Proff, P. Impact of a non-fluoridated microcrystalline hydroxyapatite dentifrice on enamel caries progression in highly caries-susceptible orthodontic patients: A randomized, controlled 6-month trial. J. Investig. Clin. Dent. 2019, 10, e12399. [Google Scholar] [CrossRef] [Green Version]
  32. Bossù, M.; Saccucci, M.; Salucci, A.; Giorgio, G.D.; Bruni, E.; Uccelletti, D.; Sarto, M.S.; Familiari, G.; Relucenti, M.; Polimeni, A. Enamel remineralization and repair results of biomimetic hydroxyapatite toothpaste on deciduous teeth: An effective option to fluoride toothpaste. J. Nanobiotech 2019, 17, 17. [Google Scholar] [CrossRef]
  33. Badiee, M.; Jafari, N.; Fatemi, S.; Ameli, N.; Kasraei, S.; Ebadifar, A. Comparison of the effects of toothpastes containing nanohydroxyapatite and fluoride on white spot lesions in orthodontic patients: A randomized clinical trial. Dent. Res. J. 2020, 17, 354–359. [Google Scholar]
  34. Grocholewicz, K.; Matkowska-Cichocka, G.; Makowiecki, P.; Droździk, A.; Ey-Chmielewska, H.; Dziewulska, A.; Tomaski, M.; Trybek, G.; Janiszewska-Olszowska, J. Effect of nano-hydroxyapatite and ozone on approximal initial caries: A randomized clinical trial. Sci. Rep. 2020, 10, 11192. [Google Scholar] [CrossRef]
  35. Paszynska, E.; Pawinska, M.; Gawriolek, M.; Kaminska, I.; Otulakowska-Skrzynska, J.; Marczuk-Kolada, G.; Rzatowski, S.; Sokolowskaq, K.; Olszewska, A.; Schlagenhauf, U.; et al. Impact of a toothpaste with microcrystalline hydroxyapatite on the occurrence of early childhood caries: A 1-year randomized clinical trial. Sci. Rep. 2021, 11, 2650. [Google Scholar] [CrossRef] [PubMed]
  36. Verma, P.; Pandian, S.M. Bionic effects of nano hydroxyapatite dentifrice on demineralised surface of enamel post orthodontic debonding: In-vivo split mouth study. Prog. Orthod. 2021, 22, 39. [Google Scholar] [CrossRef] [PubMed]
  37. Butera, A.; Pascadopoli, M.; Gallo, S.; Lelli, M.; Tarterini, F.; Giglia, F.; Scribante, A. SEM/EDS Evaluation of the Mineral Deposition on a Polymeric Composite Resin of a Toothpaste Containing Biomimetic Zn-Carbonate Hydroxyapatite (microRepair®) in Oral Environment: A Randomized Clinical Trial. Polymers 2021, 13, 2740. [Google Scholar] [CrossRef] [PubMed]
  38. Butera, A.; Gallo, S.; Pascadopoli, M.; Montasser, M.A.; Abd El Latief, M.H.; Modica, G.G.; Scribante, A. Home Oral Care with Biomimetic Hydroxyapatite vs. Conventional Fluoridated Toothpaste for the Remineralization and Desensitizing of White Spot Lesions: Randomized Clinical Trial. Int. J. Environ. Res. Public Health 2022, 19, 8676. [Google Scholar] [CrossRef]
  39. Paszynska, E.; Pawinska, M.; Enax, J.; Meyer, F.; Schulze zur Wiesche, E.; May, T.W.; Amaechi, B.T.; Limeback, H.; Hernik, A.; Otulakowska-Skrzynska, J.; et al. Caries-preventing effect of a hydroxyapatite-toothpaste in adults: A 18 months double-blinded randomized clinical trial. Front. Public Health 2023, 11, 1199728. [Google Scholar] [CrossRef]
  40. Najibfard, K.; Ramalingam, K.; Chedjieu, I.; Amaechi, B.T. Remineralization of early caries by a nano-hydroxyapatite dentifrice. J. Clin. Dent. 2011, 22, 139–143. [Google Scholar]
  41. Amaechi, B.T.; AbdulAzees, P.A.; Alshareif, D.O.; Shehata, M.A.; Lima, P.P.d.C.S.; Abdollahi, A.; Kalkhorani, P.S.; Evans, V. Comparative efficacy of a hydroxyapatite and a fluoride toothpaste for prevention and remineralization of dental caries in children. BDJ Open 2019, 5, 18. [Google Scholar] [CrossRef] [Green Version]
  42. Amaechi, B.T.; Alshareif, D.O.; AbdulAzees, P.A.; Shehata, M.A.; Lima, P.P.; Abdollahi, A.; Kalkhorani, P.S.; Evans, V.; Bagheri, A.; Okoye, L.O. Anti-caries evaluation of a nano-hydroxyapatite dental lotion for use after toothbrushing: An in situ study. J. Dent. 2021, 115, 103863. [Google Scholar] [CrossRef]
  43. Amaechi, B.T.; Farah, R.; Liu, J.A.; Phillips, T.S.; Perozo, B.I.; Kataoka, Y.; Meyer, F.; Enax, J. Remineralization of molar incisor hypomineralization (MIH) with a hydroxyapatite toothpaste: An in-situ study. BDJ Open 2022, 8, 33. [Google Scholar] [CrossRef]
  44. Hüttemann, R.W.; Dönges, H. Investigations for treating hypersensitive necks of teeth with hydroxyapatite. Dtsch. Zahnärztl Z. 1987, 42, 486–488. [Google Scholar]
  45. Barone, M.; Malpassi, M. Clinical trial of a 15% supermicronized hydroxyapatite gel for dentin hypersensitivity. G. Ital. Endod. 1991, 5, 43–47. [Google Scholar] [PubMed]
  46. Park, J.J.; Park, J.B.; Kwon, Y.H.; Herr, Y.; Chung, J.H. The effects of microcrystalline hydroxyapatite containing toothpaste in the control of tooth hypersensitivity. J. Korean Acad. Periodontol. 2005, 35, 577–590. [Google Scholar] [CrossRef] [Green Version]
  47. Kim, M.S.; Chae, G.J.; Choi, S.H.; Chai, J.K.; Kim, C.K.; Cho, K.S. Effect of hydroxyapatite containing dentifrice on teeth hypersensitivity after periodontal therapy. J. Korean Acad. Periodontol. 2008, 38, 1–6. [Google Scholar] [CrossRef] [Green Version]
  48. Kang, S.J.; Kwon, Y.H.; Park, J.B.; Herr, Y.; Chung, J.H. The effects of hydroxyapatite toothpaste on tooth hypersensitivity. J. Korean Acad. Periodontol. 2009, 39, 9–16. [Google Scholar] [CrossRef] [Green Version]
  49. Kim, S.H.; Park, J.B.; Lee, C.W.; Koo, K.T.; Kim, T.I.; Seol, Y.J.; Lee, Y.M.; Ku, Y.; Chung, C.P.; Rhyu, I.C. The clinical effects of a hydroxyapatite containing toothpaste for dentine hypersensitivity. J. Korean Acad. Periodontol. 2009, 39, 87–94. [Google Scholar] [CrossRef] [Green Version]
  50. Orsini, G.; Procaccini, M.; Manzoli, L.; Giuliodori, F.; Lorenzini, A.; Putignano, A. A double-blind randomized-controlled trial comparing the desensitizing efficacy of a new dentifrice containing carbonate/hydroxyapatite nanocrystals and a sodium fluoride/potassium nitrate dentifrice. J. Clin. Periodontol. 2010, 37, 510–517. [Google Scholar] [CrossRef]
  51. Shetty, S.; Kohad, R.; Yeltiwar, R. Hydroxyapatite as an in-office agent for tooth hypersensitivity: A clinical and scanning electron microscopic study. J. Periodontol. 2010, 81, 1781–1789. [Google Scholar] [CrossRef]
  52. Browning, W.D.; Cho, S.D.; Deschepper, E.J. Effect of a nano-hydroxyapatite paste on bleaching-related tooth sensitivity. J. Esthet. Restor. Dent. 2012, 24, 268–276. [Google Scholar] [CrossRef] [PubMed]
  53. Orsini, G.; Procaccini, M.; Manzoli, L.; Sparabombe, S.; Tiriduzzi, P.; Bambini, F.; Putignano, A. A 3-day randomized clinical trial to investigate the desensitizing properties of three dentifrices. J. Periodontol. 2013, 84, e65–e73. [Google Scholar] [CrossRef] [PubMed]
  54. Jena, A.; Shashirekha, G. Comparison of efficacy of three different desensitizing agents for in-office relief of dentin hypersensitivity: A 4 weeks clinical study. J. Conserv. Dent. 2015, 18, 389–393. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Pinojj, A.; Shetty, A.; Shetty, D.; Shetty, S. A comparison of clinical efficacy of dentifrices containing calcium sodium phosphosilicate, nanoparticle hydroxyapatite and a dentifrice containing casein phosphopeptide amorphous calcium phosphate on dentinal hypersensitivity: A comparative triple blind randomized study. Adv. Hum. Biol. 2014, 4, 57–64. [Google Scholar]
  56. Reddy, S.; Prasad, M.G.S.; Prasad, S.; Bhowmik, N.; Ashwini, N.; Sravya, L.; Singh, S. The effect of pro-argin technology vs nano technology using commercially available dentifrice: A comparative study. Int. J. Appl. Dent. Sci. 2014, 1, 26–30. [Google Scholar]
  57. Vano, M.; Derchi, G.; Barone, A.; Covani, U. Effectiveness of nano-hydroxyapatite toothpaste in reducing dentin hypersensitivity: A double-blind randomized controlled trial. Quintessence Int. 2014, 45, 703–710. [Google Scholar]
  58. Narmatha, V.J.; Thakur, S. An in-vivo comparative study of the efficacy of Propolis, nano-hydroxyapatite and potassium nitrate-containing desensitizing agents. RRJDS 2014, 2, 113–118. [Google Scholar]
  59. Amin, M.; Mehta, R.; Duseja, S.; Desai, K. Evaluation of the efficacy of commercially available nano hydroxypatite paste (Aclaim) as a desensitizing agent. Adv. Human Biol. 2015, 5, 34–38. [Google Scholar]
  60. Gopinath, N.M.; John, J.; Nagappan, N.; Prabhu, S.; Kumar, E.S. Evaluation of dentifrice containing nano-hydroxyapatite for dentinal hypersensitivity: A randomized controlled trial. J. Int. Oral Health 2015, 7, 118–122. [Google Scholar]
  61. Lee, S.-Y.; Jung, H.-I.; Jung, B.-Y.; Cho, Y.-S.; Kwon, H.-K.; Kim, B.-I. Desensitizing efficacy of nano-carbonate apatite dentifrice and Er,Cr:YSGG laser: A randomized clinical trial. Photomed. Laser Surg. 2015, 33, 9–14. [Google Scholar] [CrossRef]
  62. Vano, M.; Derchi, G.; Barone, A.; Genovesi, A.; Covani, U. Tooth bleaching with hydrogen peroxide and nano-hydroxyapatite: A 9-month follow-up randomized clinical trial. Int. J. Dent. Hyg. 2015, 13, 301–307. [Google Scholar] [CrossRef]
  63. Anand, S.; Rejula, F.; Sam, J.V.G.; Christaline, R.; Nair, M.G.; Dinakaran, S. Comparative evaluation of effect of nano-hydroxyapatite and 8% arginine containing toothpastes in managing dentin hypersensitivity: Double blind randomized clinical trial. Acta Medica 2017, 60, 114–119. [Google Scholar] [CrossRef] [Green Version]
  64. Makeeva, I.M.; Polyakova, M.A.; Doroshina, V.Y.; Sokhova, I.A.; Arakelyan, M.G.; Makeeva, M.K. Efficiency of paste and suspension with nano-hydroxyapatite on the sensitivity of teeth with gingival recession. Stomatologiia 2018, 97, 23–27. [Google Scholar] [CrossRef]
  65. Amaechi, B.T.; Lemke, K.C.; Saha, S.; Gelfond, J. Clinical efficacy in relieving dentin hypersensitivity of nanohydroxyapatite-containing cream: A randomized controlled trial. Open Dent. J. 2018, 12, 572–585. [Google Scholar] [CrossRef] [PubMed]
  66. Vano, M.; Derchi, G.; Barone, A.; Pinna, R.; Usai, P.; Covani, U. Reducing dentine hypersensitivity with nano-hydroxyapatite toothpaste: A double-blind randomized controlled trial. Clin. Oral Investig. 2018, 22, 313–320. [Google Scholar] [CrossRef] [PubMed]
  67. Al Asmari, D.; Khan, M.K. Evaluate efficacy of desensitizing toothpaste containing zinc-carbonate hydroxyapatite nanocrystals: Non-comparative eight-week clinical study. J. Int. Soc. Prev. Community Dent. 2019, 9, 566–570. [Google Scholar] [PubMed]
  68. Kondyurova, E.V.; Lisevtsova, J.V.; Eliseykina, E.V.; Vilikotskiy, A.E.; Zakirova, S.A. Clinical evaluation of a dentifrice containing Nhap for the reduction of dentin hypersensitivity. Int. J. Oral Dent. Health 2019, 5, 104. [Google Scholar] [CrossRef]
  69. Alencar, C.D.; Ortiz, M.I.; Silva, F.A.; Alves, E.B.; Araújo, J.L.; Silva, C.M. Effect of nanohydroxyapatite associated with photobiomodulation in the control of dentin hypersensitivity: A randomized, double-blind, placebo-controlled clinical trial. Am. J. Dent. 2020, 33, 138–144. [Google Scholar]
  70. Ding, P.H.; Dai, A.; Hu, H.J.; Huang, J.P.; Liu, J.M.; Chen, L.L. Efficacy of nano-carbonate apatite dentifrice in relief from dentine hypersensitivity following non-surgical periodontal therapy: A randomized controlled trial. BMC Oral Health 2020, 20, 170. [Google Scholar] [CrossRef] [PubMed]
  71. Alharith, D.N.; Al-Omari, M.; Almnea, R.; Basri, R.; Alshehri, A.H.; Al-Nufiee, A.A. Clinical efficacy of single application of plain nano-hydroxyapatite paste in reducing dentine hypersensitivity—A randomized clinical trial. Saudi Endod. J. 2021, 11, 24–30. [Google Scholar]
  72. Amaechi, B.T.; Lemke, K.C.; Saha, S.; Luong, M.N.; Gelfond, J. Clinical efficacy of nanohydroxyapatite-containing toothpaste at relieving dentin hypersensitivity: An 8 weeks randomized control trial. BDJ Open 2021, 7, 23. [Google Scholar] [CrossRef]
  73. Ehlers, V.; Reuter, A.K.; Kehl, E.B.; Enax, J.; Meyer, F.; Schlecht, J.; Schmidtmann, I.; Deschner, J. Efficacy of a toothpaste based on microcrystalline hydroxyapatite on children with hypersensitivity caused by MIH: A randomised controlled trial. Oral Health Prev. Dent. 2021, 19, 647–658. [Google Scholar]
  74. Polyakova, M.; Sokhova, I.; Doroshina, V.; Arakelyan, M.; Novozhilova, N.; Babina, K. The effect of toothpastes containing hydroxyapatite, fluoroapatite, and Zn-Mg-hydroxyapatite nanocrystals on dentin hypersensitivity: A randomized clinical trial. J. Int. Soc. Prev. Commun. Dent. 2022, 12, 252. [Google Scholar]
  75. Vlasova, N.; Samusenkov, V.; Novikova, I.; Nikolenko, D.; Nikolashvili, N.; Gor, I.; Danilina, A. Clinical efficacy of hydroxyapatite toothpaste containing Polyol Germanium Complex (PGC) with threonine in the treatment of dentine hypersensitivity. Saudi Dent. J. 2022, 34, 310–314. [Google Scholar] [CrossRef] [PubMed]
  76. Butera, A.; Pascadopoli, M.; Pellegrini, M.; Trapani, B.; Gallo, S.; Radu, M.; Scribante, A. Biomimetic hydroxyapatite paste for molar-incisor hypomineralization: A randomized clinical trial. Oral Dis. 2022, preprint. [Google Scholar] [CrossRef] [PubMed]
  77. Harks, I.; Jockel-Schneider, Y.; Schlagenhauf, U.; May, T.W.; Gravemeier, M.; Prior, K.; Petersilka, G.; Ehmke, B. Impact of the Daily Use of a Microcrystal Hydroxyapatite Dentifrice on De Novo Plaque Formation and Clinical/Microbiological Parameters of Periodontal Health. A Randomized Trial. PLoS ONE 2016, 11, e0160142. [Google Scholar] [CrossRef] [Green Version]
  78. Doroshina, V.Y.; Sokhova, I.A.; Polyakova, M.A.; Margaryan, E.G. Comparative evaluation of the effectiveness of oral care products in inflammatory disease of the oral cavity, accompanied by teeth hyperesthesia. New Am. Med. J. 2019, 13, 34–40. [Google Scholar]
  79. Monterubbianesi, R.; Sparabombe, S.; Tosco, V.; Profili, F.; Mascitti, M.; Hosein, A.; Putignano, A.; Orsini, G. Can Desensitizing Toothpastes Also Have an Effect on Gingival Inflammation? A Double-Blind, Three-Treatment Crossover Clinical Trial. Int. J. Environ. Res. Public Health 2020, 17, 8927. [Google Scholar] [CrossRef]
  80. Brauner, E.; Di Cosola, M.; Ambrosino, M.; Cazzolla, A.P.; Dioguardi, M.; Nocini, R.; Topi, S.; Mancini, A.; Maggiore, M.E.; Scacco, S.; et al. Efficacy of bioactivated anticalculus toothpaste on oral health: A single-blind, parallel-group clinical study. Minerva Dent. Oral Sci. 2022, 71, 31–38. [Google Scholar] [CrossRef] [PubMed]
  81. Andrea, B.; Lanteri, V.; Martina, B.; Fabio, D.F.; Eleonora, F.; Annamaria, G. Proactive therapy in maintenance of periodontal orthodontic patient. Int. J. Clin. Dent. 2022, 15, 39–47. [Google Scholar]
  82. Niwa, M.; Sato, T.; Li, W.; Aoki, H.; Aoki, H.; Daisaku, T. Polishing and whitening properties of toothpaste containing hydroxyapatite. J. Mater. Sci. Mater. Med. 2001, 12, 277–281. [Google Scholar] [CrossRef]
  83. Raoufi, S.; Birkhed, D. Effect of whitening toothpastes on tooth staining using two different colour-measuring devices-a 12-week clinical trial. Int. Dent. J. 2010, 60, 419–423. [Google Scholar] [PubMed]
  84. Woo, G.-J.; Kim, E.-K.; Jeong, S.-H.; Song, K.-B.; Goo, H.-J.; Jeon, E.-S.; Choi, Y.-H. Comparison of the whitening effect of toothpastes containing 0.25% hydroxyapatite and 0.75% hydrogen peroxide. J. Korean Acad. Oral Health 2014, 38, 3–9. [Google Scholar] [CrossRef]
  85. Bommer, C.; Flessa, H.P.; Xu, X.; Kunzelmann, K.H. Hydroxyapatite and self-assembling peptide matrix for non-oxidizing tooth whitening. J. Clin. Dent. 2018, 29, 57–63. [Google Scholar]
  86. Steinert, S.; Kuchenbecker, J.; Meyer, F.; Simader, B.; Zwanzig, K.; Enax, J. Whitening effects of a novel oral care gel with biomimetic hydroxyapatite: A 4-week observational pilot study. Biomimetics 2020, 5, 65. [Google Scholar] [CrossRef] [PubMed]
  87. Andersson, A.; Sköld-Larsson, K.; Hallgren, A.; Petersson, L.G.; Twetman, S. Effect of a dental cream containing amorphous cream phosphate complexes on white spot lesion regression assessed by laser fluorescence. Oral Health Prev. Dent. 2007, 5, 229–233. [Google Scholar] [PubMed]
  88. Bailey, D.L.; Adams, G.G.; Tsao, C.E.; Hyslop, A.; Escobar, K.; Manton, D.J.; Reynolds, E.C.; Morgan, M.V. Regression of post-orthodontic lesions by a remineralizing cream. J. Dent. Res. 2009, 88, 1148–1153. [Google Scholar] [CrossRef]
  89. Rao, S.K.; Bhat, G.S.; Aradhya, S.; Devi, A.; Bhat, M. Study of the efficacy of toothpaste containing casein phosphopeptide in the prevention of dental caries: A randomized controlled trial in 12- to 15-year-old high caries risk children in Bangalore, India. Caries Res. 2009, 43, 430–435. [Google Scholar] [CrossRef]
  90. Uysal, T.; Amasyali, M.; Koyuturk, A.E.; Ozcan, S. Effects of different topical agents on enamel demineralization around orthodontic brackets: An in vivo and in vitro study. Aust. Dent. J. 2010, 55, 268–274. [Google Scholar] [CrossRef]
  91. Bröchner, A.; Christensen, C.; Kristensen, B.; Tranæus, S.; Karlsson, L.; Sonnesen, L.; Twetman, S. Treatment of post-orthodontic white spot lesions with casein phosphopeptide-stabilised amorphous calcium phosphate. Clin. Oral Investig. 2011, 15, 369–373. [Google Scholar] [CrossRef]
  92. Akin, M.; Basciftci, F.A. Can white spot lesions be treated effectively? Angle Orthod. 2012, 82, 770–775. [Google Scholar] [CrossRef]
  93. Sitthisettapong, T.; Phantumvanit, P.; Huebner, C.; Derouen, T. Effect of CPP-ACP paste on dental caries in primary teeth: A randomized trial. J. Dent. Res. 2012, 91, 847–852. [Google Scholar] [CrossRef]
  94. Wang, J.X.; Yan, Y.; Wang, X.J. Clinical evaluation of remineralization potential of casein phosphopeptide amorphous calcium phosphate nanocomplexes for enamel decalcification in orthodontics. Chin. Med. J. 2012, 125, 4018–4021. [Google Scholar] [PubMed]
  95. Krithikadatta, J.; Fredrick, C.; Abarajithan, M.; Kandaswamy, D. Remineralisation of occlusal white spot lesion with a combination of 10% CPP-ACP and 0.2% sodium fluoride evaluated using Diagnodent: A pilot study. Oral Health Prev. Dent. 2013, 11, 191–196. [Google Scholar] [PubMed]
  96. Plonka, K.A.; Pukallus, M.L.; Holcombe, T.F.; Barnett, A.G.; Walsh, L.J.; Seow, W.K. Randomized controlled trial: A randomized controlled clinical trial comparing a remineralizing paste with an antibacterial gel to prevent early childhood caries. Pediatr. Dent. 2013, 35, 8–12. [Google Scholar] [PubMed]
  97. Aykut-Yetkiner, A.; Kara, N.; Ateş, M.; Ersin, N.; Ertuğrul, F. Does casein phosphopeptide amorphous calcium phosphate provide remineralization on white spot lesions and inhibition of Streptococcus mutans? J. Clin. Pediatr. Dent. 2014, 38, 302–306. [Google Scholar] [CrossRef]
  98. Yazıcıoğlu, O.; Ulukapi, H. The investigation of non-invasive techniques for treating early approximal carious lesions: An in vivo study. Int. Dent. J. 2014, 64, 1–11. [Google Scholar] [CrossRef] [PubMed]
  99. Zhang, Q.; Zou, J.; Yang, R.; Zhou, X. Remineralization effects of casein phosphopeptide-amorphous calcium phosphate crème on artificial early enamel lesions of primary teeth. Int. J. Paediatr. Dent. 2011, 21, 374–381. [Google Scholar] [CrossRef] [PubMed]
  100. Llena, C.; Leyda, A.M.; Forner, L. CPP-ACP and CPP-ACFP versus fluoride varnish in remineralisation of early caries lesions. A prospective study. Eur. J. Paediatr. Dent. 2015, 16, 181–186. [Google Scholar]
  101. Memarpour, M.; Fakhraei, E.; Dadaein, S.; Vossoughi, M. Efficacy of fluoride varnish and casein phosphopeptide-amorphous calcium phosphate for remineralization of primary teeth: A randomized clinical trial. Med. Princ. Pract. 2015, 24, 231–237. [Google Scholar] [CrossRef]
  102. Sitthisettapong, T.; Doi, T.; Nishida, Y.; Kambara, M.; Phantumvanit, P. Effect of CPP-ACP Paste on Enamel Carious Lesion of Primary Upper Anterior Teeth Assessed by Quantitative Light-Induced Fluorescence: A One-Year Clinical Trial. Caries Res. 2015, 49, 434–441. [Google Scholar] [CrossRef]
  103. Sim, C.P.C.; Wee, J.; Xu, Y.; Cheung, Y.-B.; Soong, Y.-L.; Manton, D.J. Anti-caries effect of CPP-ACP in irradiated nasopharyngeal carcinoma patients. Clin. Oral Investig. 2015, 19, 1005–1011. [Google Scholar] [CrossRef]
  104. Esenlik, E.; Uzer Çelik, E.; Bolat, E. Efficacy of a casein phosphopeptide amorphous calcium phosphate (CPP-ACP) paste in preventing white spot lesions in patients with fixed orthodontic appliances: A prospective clinical trial. Eur. J. Paediatr. Dent. 2016, 17, 274–280. [Google Scholar]
  105. Güçlü, Z.A.; Alaçam, A.; Coleman, N.J. A 12-Week Assessment of the Treatment of White Spot Lesions with CPP-ACP Paste and/or Fluoride Varnish. Biomed. Res. Int. 2016, 2016, 8357621. [Google Scholar] [CrossRef] [Green Version]
  106. Munjal, D.; Garg, S.; Dhindsa, A.; Sidhu, G.K.; Sethi, H.S. Assessment of White Spot Lesions and In-Vivo Evaluation of the Effect of CPP-ACP on White Spot Lesions in Permanent Molars of Children. J. Clin. Diagn. Res. 2016, 10, ZC149-54. [Google Scholar] [CrossRef]
  107. Singh, S.; Singh, S.P.; Goyal, A.; Utreja, A.K.; Jena, A.K. Effects of various remineralizing agents on the outcome of post-orthodontic white spot lesions (WSLs): A clinical trial. Prog. Orthod. 2016, 17, 25. [Google Scholar] [CrossRef] [Green Version]
  108. Karabekiroğlu, S.; Ünlü, N.; Küçükyilmaz, E.; Şener, S.; Botsali, M.S.; Malkoç, S. Treatment of post-orthodontic white spot lesions with CPP-ACP paste: A three year follow up study. Dent. Mater. J. 2017, 36, 791–797. [Google Scholar] [CrossRef] [Green Version]
  109. Mendes, A.C.; Restrepo, M.; Bussaneli, D.; Zuanon, A.C. Use of Casein Amorphous Calcium Phosphate (CPP-ACP) on White-spot Lesions: Randomised Clinical Trial. Oral Health Prev. Dent. 2018, 16, 27–31. [Google Scholar] [PubMed]
  110. Wang, Y.H.; Liu, F.; Liu, H.N.; Wang, Q.X.; Xing, W.Z.; Li, Z.C. Impact assessment on enamel remineralization after orthodontic treatment with casein phosphopeptide calcium phosphate complex. Shanghai Kou Qiang Yi Xue 2018, 27, 382–385. [Google Scholar] [PubMed]
  111. Bobu, L.; Murariu, A.; Topor, G.; Beznea, A.; Vasluianu, R. Comparative evaluation of casein phosphopeptide—Amorphous calcium phosphate and fluoride in managing early caries lesions. Rev. Chim. 2019, 70, 3746–3749. [Google Scholar] [CrossRef]
  112. Tingyun, W.; Detang, W.; Youjia, Z.; Qiong, R.; Aimin, W.; Shangqun, H.; Xiaofang, Z. Effects of different types of fluoride-free toothpaste on the remineralization of enamel after acid erosion: An in vivo study. Chin. J. Tiss. Eng. Res. 2019, 23, 2842–2846. [Google Scholar]
  113. Al-Batayneh, O.B.; Bani Hmood, E.I.; Al-Khateeb, S.N. Assessment of the effects of a fluoride dentifrice and GC Tooth Mousse on early caries lesions in primary anterior teeth using quantitative light-induced fluorescence: A randomised clinical trial. Eur. Arch. Paediatr. Dent. 2020, 21, 85–93. [Google Scholar] [CrossRef] [PubMed]
  114. Bangi, S.L.; Konda, P.; Talapaneni, A.K.; Fatima, A.; Hussain, A. Evaluation of three commercially available materials in reducing the white spot lesions during fixed orthodontic treatment: A prospective randomized controlled trial. J. Ind. Orthod. Soc. 2020, 54, 100–105. [Google Scholar]
  115. Perić, T.; Marković, D.; Tomić-Spirić, V.; Petrović, B.; Perić-Popadić, A.; Marković, E. Clinical efficacy of casein phosphopeptide-amorphous calcium phosphate and casein phosphopeptide-amorphous calcium fluoride phosphate and their influence on the quality of life in patients with Sjögren’s syndrome. Srp. Arh. Celok. Lek. 2020, 148, 528–534. [Google Scholar] [CrossRef]
  116. Ashour, D.G.; Farid, M.R.; Mosallam, R.S.; Abouauf, E.A. Effect of CPP-ACP pastes with/without fluoride on white spot lesion progression, salivary pH, and fluoride release in high caries risk patients: A randomized clinical trial. J. Int. Oral Health 2021, 13, 336–343. [Google Scholar]
  117. Juárez-López, M.L.A.; Gómez-Rivas, Y.C.; Murrieta-Pruneda, F. Casein-phosphopeptide-amorphous-calcium-phosphate plus brushing with fluoride toothpaste for remineralization of early caries. Acta Pediátrica México 2021, 42, 272–279. [Google Scholar]
  118. El-Sherif, S.A.; Shaalan, O.O.; Hamza, N.K.; El Baz, M.A. Remineralization Potential of Pearl Powder Compared to Casein Phosphopeptide Amorphous Calcium Phosphate on Enamel White Spot Lesions (Randomized Clinical Trial). J. Pharm. Negat. Results 2022, 13, 1662–1671. [Google Scholar]
  119. Hamdi, K.; Hamama, H.H.; Motawea, A.; Fawzy, A.; Mahmoud, S.H. Long-term evaluation of early-enamel lesions treated with novel experimental tricalcium silicate paste: A 2-year randomized clinical trial. J. Esthet. Restor. Dent. 2022, 34, 1113–1121. [Google Scholar] [CrossRef]
  120. Olgen, I.C.; Sonmez, H.; Bezgin, T. Effects of different remineralization agents on MIH defects: A randomized clinical study. Clin. Oral. Investig. 2022, 26, 3227–3238. [Google Scholar] [CrossRef]
  121. Salah, R.; Afifi, R.R.; Kehela, H.A.; Aly, N.M.; Rashwan, M. Efficacy of a novel bioactive glass in the treatment of enamel white spot lesions: A randomized controlled trial. J. Evid. Based Dent. Pract. 2022, 22, 101725. [Google Scholar] [CrossRef]
  122. Simon, L.S.; Dash, J.K.; U, D.; Philip, S.; Sarangi, S. Management of Post Orthodontic White Spot Lesions Using Resin Infiltration and CPP-ACP Materials- A Clinical Study. J. Clin. Paeditr. Dent. 2022, 46, 70–74. [Google Scholar]
  123. Srinivasan, N.; Kavitha, M.; Loganathan, S.C. Comparison of the remineralization potential of CPP-ACP and CPP-ACP with 900 ppm fluoride on eroded human enamel: An in situ study. Arch. Oral. Biol. 2010, 55, 541–544. [Google Scholar] [CrossRef]
  124. Shen, P.; Walker, G.D.; Yuan, Y.; Reynolds, C.; Stanton, D.P.; Fernando, J.R.; Reynolds, E.C. Importance of bioavailable calcium in fluoride dentifrices for enamel remineralization. J. Dent. 2018, 78, 59–64. [Google Scholar] [CrossRef] [PubMed]
  125. Perić, T.; Markovic, D.; Petrovic, B.; Radojevic, V.; Todorovic, T.; Radicevic, B.A.; Heinemann, R.J.; Susic, G.; Popadic, A.P.; Spiric, V.T. Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjögren’s syndrome. Clin. Oral Investig. 2015, 19, 2153–2165. [Google Scholar] [CrossRef] [PubMed]
  126. Garry, A.P.; Flannigan, N.L.; Cooper, L.; Komarov, G.; Burnside, G.; Higham, S.M. A randomised controlled trial to investigate the remineralising potential of Tooth Mousse™ in orthodontic patients. J. Orthod. 2017, 44, 147–156. [Google Scholar] [CrossRef] [PubMed]
  127. Zawaideh, F.I.; Owais, A.I.; Mushtaha, S. Effect of CPP-ACP or a potassium nitrate sodium fluoride dentifrice on enamel erosion prevention. J. Clin. Paediatr. Dent. 2017, 41, 135–140. [Google Scholar] [CrossRef]
  128. Yu, H.; Jiang, N.-W.; Ye, X.-Y.; Zheng, H.-Y.; Attin, T.; Cheng, H. In situ effect of Tooth Mousse containing CPP-ACP on human enamel subjected to in vivo acid attacks. J. Dent. 2018, 76, 40–45. [Google Scholar] [CrossRef] [Green Version]
  129. de Oliveira, P.R.A.; Barboza, C.M.; Barreto, L.S.C.; Tostes, M.A. Effect of CPP-ACP on remineralization of artificial caries-like lesion: An in situ study. Braz. Oral Res. 2020, 34, e061. [Google Scholar] [CrossRef]
  130. de Oliveira, P.R.A.; Barreto, L.S.D.C.; Tostes, M.A. Effectiveness of CPP-ACP and fluoride products in tooth remineralization. Int. J. Dent. Hyg. 2022, 20, 635–642. [Google Scholar] [CrossRef]
  131. Kumar, A.; Goyal, A.; Gauba, K.; Kapur, A.; Singh, S.K.; Mehta, S.K. An evaluation of remineralised MIH using CPP-ACP and fluoride varnish: An in-situ and in-vitro study. Eur. Arch. Paediatr. Dent. 2022, 23, 79–97. [Google Scholar] [CrossRef]
  132. Borges, B.C.; Borges, J.S.; de Melo, C.D.; Pinheiro, I.V.; Santos, A.J.; Braz, R.; Montes, M.A. Efficacy of a novel at-home bleaching technique with carbamide peroxides modified by CPP-ACP and its effect on the microhardness of bleached enamel. Oper. Dent. 2011, 36, 521–528. [Google Scholar] [CrossRef] [Green Version]
  133. Özgül, B.M.; Saat, S.; Sönmez, H.; Oz, F.T. Clinical evaluation of desensitizing treatment for incisor teeth affected by molar-incisor hypomineralization. J. Clin. Pediatr. Dent. 2013, 38, 101–105. [Google Scholar] [CrossRef]
  134. Maghaireh, G.A.; Alzraikat, H.; Guidoum, A. Assessment of the effect of casein phosphopeptide-amorphous calcium phosphate on postoperative sensitivity associated with in-office vital tooth whitening. Oper. Dent. 2014, 39, 239–247. [Google Scholar] [CrossRef] [PubMed]
  135. Mahesuti, A.; Duan, Y.L.; Wang, G.; Cheng, X.R.; Matis, B.A. Short-term Efficacy of Agents Containing KNO3 or CPP-ACP in Treatment of Dentin Hypersensitivity. Chin. J. Dent. Res. 2014, 17, 43–47. [Google Scholar] [PubMed]
  136. Zhang, D.; Zhang, X.; Peng, H.; Sun, H. Casein phosphopeptide-amorphous calcium phosphate nanocomplexes as a preventive agent for radiation caries and dental sensitivity in irradiated head and neck cancer patients. Chin. J. Clin. Oncol. 2014, 41, 1293–1296. [Google Scholar]
  137. Konekeri, V.; Bennadi, D.; Manjunath, M.; Kshetrimayum, N.; Siluvai, S.; Reddy, C.V.K. A clinical study to assess the effectiveness of CPP-ACP (casein phosphopeptide-amorphous calcium phosphate) versus potassium-nitrate (KNO3) on cervical dentine hypersensitivity. J. Young Pharm. 2015, 7, 217–224. [Google Scholar] [CrossRef]
  138. Nanjundasetty, J.K.; Ashrafulla, M. Efficacy of desensitizing agents on postoperative sensitivity following an in-office vital tooth bleaching: A randomized controlled clinical trial. J. Conserv. Dent. 2016, 19, 207–211. [Google Scholar] [CrossRef] [Green Version]
  139. Tarique, N.; Awan, R.; Saleh, M.I. Vital tooth bleaching and management of post operative sensitivity: A clinical trial evaluating the efficacy of different desensitizing materials. Pak. J. Med. Health Sci. 2017, 11, 1564–1567. [Google Scholar]
  140. Pasini, M.; Giuca, M.R.; Scatena, M.; Gatto, R.; Caruso, S. Molar incisor hypomineralization treatment with casein phosphopeptide and amorphous calcium phosphate in children. Minerva Stomatol. 2018, 67, 20–25. [Google Scholar] [CrossRef]
  141. Yassin, O.; Milly, H. Effect of CPP-ACP on efficacy and postoperative sensitivity associated with at-home vital tooth bleaching using 20% carbamide peroxide. Clin. Oral Investig. 2019, 23, 1555–1559. [Google Scholar] [CrossRef]
  142. Adil, H.M.; Jouhar, R.; Ahmed, M.A.; Basha, S.; Ahmed, N.; Abbasi, M.S.; Maqsood, A.; Nagarajappa, A.K.; Alam, M.K. Comparison of casein phosphopeptide with potassium nitrate and sodium monofluorophosphate desensitizing efficacy after in-office vital bleaching—A randomized trial. Appl. Sci. 2021, 11, 9291. [Google Scholar] [CrossRef]
  143. Gümüştaş, B.; Dikmen, B. Effectiveness of remineralization agents on the prevention of dental bleaching induced sensitivity: A randomized clinical trial. Int. J. Dent. Hyg. 2021, 20, 650–657. [Google Scholar] [CrossRef] [PubMed]
  144. Tiwari, A.; Jain, R.K. Comparative evaluation of white spot lesions incidence between NovaMin, Probiotic and fluoride containing dentifrices during orthodontic treatment using laser fluorescence- a prospective randomized controlled trial. Clin. Investig. Orthog. 2023, 82, 75–82. [Google Scholar] [CrossRef]
  145. Du, M.Q.; Bian, Z.; Jiang, H.; Greenspan, D.C.; Burwell, A.K.; Zhong, J.; Tai, B.J. Clinical evaluation of a dentifrice containing calcium sodium phosphosilicate (NovaMin) for the treatment of dentin hypersensitivity. Am. J. Dent. 2008, 21, 210–214. [Google Scholar]
  146. Litkowski, L.; Greenspan, D.C. A clinical study of the effect of calcium sodium phosphosilicate on dentin hypersensitivity-Proof of principle. J. Clin. Dent. 2010, 21, 77–81. [Google Scholar] [PubMed]
  147. Narongdej, T.; Sakoolnamarka, R.; Boonroung, T. The effectiveness of a calcium sodium phosphosilicate desensitizer in reducing cervical dentin hypersensitivity: A pilot study. J. Am. Dent. Assoc. 2010, 141, 995–999. [Google Scholar] [CrossRef]
  148. Pradeep, A.R.; Sharma, A. Comparison of clinical efficacy of a dentifrice containing calcium sodium phosphosilicate to a dentifrice containing potassium nitrate and to a placebo on dentinal hypersensitivity: A randomized clinical trial. J. Periodontol. 2010, 81, 995–999. [Google Scholar] [CrossRef] [PubMed]
  149. Salian, S.; Thakur, S.; Kulkarni, S.; Latorre, G. A randomized controlled clinical study evaluating the efficacy of two desensitizing dentifrices. J. Clin. Dent. 2010, 21, 82–87. [Google Scholar] [PubMed]
  150. Sharma, N.; Roy, S.; Kakar, A.; Greenspan, D.C.; Scott, R. A clinical study comparing oral formulations containing 7.5% calcium sodium phosphosilicate (Novamin®), 5% potassium nitrate, and 0.4% stannous fluoride for the management of dentin hypersensitivity. J. Clin. Dent. 2010, 21, 88–92. [Google Scholar]
  151. West, N.X.; Macdonald, E.L.; Jones, S.B.; Claydon, N.C.A.; Hughes, N.; Jeffery, P. Randomized in situ clinical study comparing the ability of two new desensitizing toothpaste technologies to occlude patent dentin tubules. J. Clin. Dent. 2011, 22, 82–89. [Google Scholar] [PubMed]
  152. Pradeep, A.R.; Agarwal, E.; Naik, S.B.; Bajaj, P.; Kalra, N. Comparison of efficacy of three commercially available dentrifices on dentinal hypersensitivity: A randomized clinical trial. Aust. Dent. J. 2012, 57, 429–434. [Google Scholar] [CrossRef]
  153. Rajesh, K.S.; Hedge, S.; Kumar, A.; Shetty, D.G. Evaluation of the efficacy of a 5% calcium sodium phosphosilicate (Novamin®) containing dentifrice for the relief of dentinal hypersensitivity: A clinical study. Ind. J. Dent. Res. 2012, 23, 363–367. [Google Scholar]
  154. Surve, S.M.; Acharya, A.B.; Shetty, A.; Thakur, S.L. Efficacy of calcium sodium phosphosilicate in managing dentinal hypersensitivity. Gen. Dent. 2012, 60, e308–e311. [Google Scholar] [PubMed]
  155. Acharya, A.B.; Surve, S.M.; Thakur, S.L. A clinical study of the effect of calcium sodium phosphosilicate on dentin hypersensitivity. J. Clin. Exp. Dent. 2013, 5, e18–e22. [Google Scholar] [CrossRef]
  156. Pintado-Palomino, K.; Peitl Filho, O.; Zanotto, E.D.; Tirapelli, C. A clinical, randomized, controlled study on the use of desensitizing agents during tooth bleaching. J. Dent. 2015, 43, 1099–1105. [Google Scholar] [CrossRef] [PubMed]
  157. Samuel, S.R.; Khatri, S.G.; Acharya, S.; Patil, S.T. Evaluation of instant desensitization after a single topical application over 30 days: A randomized trial. Aust. Dent. J. 2015, 60, 336–342. [Google Scholar] [CrossRef] [PubMed]
  158. Majji, P.; Murthy, K.R. Clinical efficacy of four interventions in the reduction of dentinal hypersensitivity: A 2-month study. Ind. J. Dent. Res. 2016, 27, 477–482. [Google Scholar] [CrossRef] [PubMed]
  159. Sufi, F.; Hall, C.; Mason, S.; Shaw, D.; Kennedy, L.; Gallob, J.T. Efficacy of an experimental toothpaste containing 5% calcium sodium phosphosilicate in the relief of dentin hypersensitivity: An 8-week randomized study (Study 1). Am. J. Dent. 2016, 29, 93–100. [Google Scholar]
  160. Sufi, F.; Hall, C.; Mason, S.; Shaw, D.; Milleman, J.; Milleman, K. Efficacy of an experimental toothpaste containing 5% calcium sodium phosphosilicate in the relief of dentin hypersensitivity: An 8-week randomized study (Study 2). Am. J. Dent. 2016, 29, 101–109. [Google Scholar]
  161. Athuluru, D.; Reddy, C.; Sudhir, K.; Kumar, K.; Gomasani, S.; Nagarakanti, S. Evaluation and comparison of efficacy of three desensitizing dentifrices on dentinal hypersensitivity and salivary biochemical characteristics: A randomized controlled trial. Dent. Res. J. 2017, 14, 150–157. [Google Scholar]
  162. Hall, C.; Mason, S.; Cooke, J. Exploratory randomised controlled clinical study to evaluate the comparative efficacy of two occluding toothpastes—A 5% calcium sodium phosphosilicate toothpaste and an 8% arginine/calcium carbonate toothpaste—for the longer-term relief of dentine hypersensitivity. J. Dent. 2017, 60, 36–43. [Google Scholar]
  163. Fu, Y.; Sufi, F.; Wang, N.; Young, S.; Feng, X. An exploratory randomised study to evaluate the efficacy of an experimental occlusion-based dentifrice in the relief of dentin hypersensitivity. Oral Health Prev. Dent. 2019, 17, 107–115. [Google Scholar]
  164. Alsherbiney, H.; El-Deeb, H.; Alsherbiney, A.; Abdou, A.; Mobarak, E.; Hamza, O. Effect of calcium sodium phosphosilicate-containing compared to nanohydroxyapatite-containing toothpastes on dentinal tubule occlusion: A randomized clinical in situ study. J. Int. Oral Health 2020, 12, 305–312. [Google Scholar]
  165. Bhowmik, E.; Pawar Chandrashekhar, D.; Sharma Hareesha, M. Comparative evaluation of fluorinol and calcium sodium phosphosilicate-containing toothpastes in the treatment of dentin hypersensitivity. Int. J. Dent. Hyg. 2021, 19, 421–428. [Google Scholar] [CrossRef] [PubMed]
  166. Ongphichetmetha, N.; Lertpimonchai, A.; Champaiboon, C. Bioactive glass and arginine dentifrices immediately relieved dentine hypersensitivity following non-surgical periodontal therapy: A randomized controlled trial. J. Periodontol. 2022, 93, 246–255. [Google Scholar] [CrossRef]
  167. Detsomboonrat, P.; Trairatvorakul, C.; Pisarnturakit, P.P. Similar 1-year caries increment after use of fluoride or non-fluoride toothpaste in infants and toddlers. Fluoride 2016, 49, 313–326. [Google Scholar]
  168. Jang, J.-H.; Oh, S.; Kim, H.-J.; Kim, D.-S. A randomized clinical trial for comparing the efficacy of desensitizing toothpastes on the relief of dentin hypersensitivity. Nat. Sci. Rep. 2023, 13, 5171. [Google Scholar] [CrossRef] [PubMed]
  169. Neurath, C.; Limeback, H.; Osmunson, B.; Connett, M.; Kanter, V.; Wells, C.R. Dental Fluorosis Trends in US Oral Health Surveys: 1986 to 2012. JDR Clin. Trans. Res. 2019, 4, 298–308. [Google Scholar] [CrossRef]
  170. Farmus, L.; Till, C.; Green, R.; Hornung, R.; Martinez Mier, E.A.; Ayotte, P.; Muckle, G.; Lanphear, B.P.; Flora, D.B. Critical windows of fluoride neurotoxicity in Canadian children. Environ. Res. 2021, 200, 111315. [Google Scholar] [CrossRef]
  171. Enax, J.; Meyer, F.; Schulze Zur Wiesche, E.; Epple, M. On the Application of Calcium Phosphate Micro- and Nanoparticles as Food Additive. Nanomaterials 2022, 12, 4075. [Google Scholar] [CrossRef]
  172. Enax, J.; Amaechi, B.T.; Farah, R.; Liu, J.A.; Schulze zur Wiesche, E.; Meyer, F. Remineralization Strategies for Teeth with Molar Incisor Hypomineralization (MIH): A Literature Review. Dent. J. 2023, 11, 80. [Google Scholar] [CrossRef]
  173. Sezer, B.; Kargul, B. Effect of Remineralization Agents on Molar-Incisor Hypomineralization-Affected Incisors: A Randomized Controlled Clinical Trial. J. Clin. Pediatr. Dent. 2022, 46, 192–198. [Google Scholar] [CrossRef] [PubMed]
  174. Sezer, B.; Tuğcu, N.; Calışkan, C.; Baş Durmus, B.; Kupets, T.; Bekiroğlu, N.; Kargül, B.; Bourgeois, D. Effect of casein phosphopeptide amorphous calcium fluoride phosphate and calcium glycerophosphate on incisors with molar-incisor hypomineralization: A cross-over, randomized clinical trial. Bio-Med. Mater. Eng. 2022, 33, 325–335. [Google Scholar] [CrossRef] [PubMed]
  175. Yilmaz, M.A.; Yildiz, P.K.; Gokkaya, B.; Bilsel, S.O.; Kargul, B. The effect of a novel toothpaste in children with white spot lesions. J. Pak. Med. Assoc. 2022, 72, 2170–2174. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Summary of the search results showing numbers of publications from each database identified and the total records included after screening and exclusion of records.
Figure 1. Summary of the search results showing numbers of publications from each database identified and the total records included after screening and exclusion of records.
Biomimetics 08 00331 g001
Table 1. (a) Hydroxyapatite (HAP) clinical trials on reducing caries or white spot lesions (WSL) or preventing erosion, listed chronologically. (b) HAP studies in situ using human enamel to measure remineralization or erosion resistance. (c) HAP clinical trials on reducing dentin hypersensitivity listed chronologically. (d) Hydroxyapatite (HAP) clinical trials on improvement of gingival health listed chronologically. (e) Hydroxyapatite (HAP) clinical trials on improving tooth appearance listed chronologically.
Table 1. (a) Hydroxyapatite (HAP) clinical trials on reducing caries or white spot lesions (WSL) or preventing erosion, listed chronologically. (b) HAP studies in situ using human enamel to measure remineralization or erosion resistance. (c) HAP clinical trials on reducing dentin hypersensitivity listed chronologically. (d) Hydroxyapatite (HAP) clinical trials on improvement of gingival health listed chronologically. (e) Hydroxyapatite (HAP) clinical trials on improving tooth appearance listed chronologically.
(a)
Study First AuthorYearTest
(HAP Used)
ControlsTrial Subjects,
Duration
OutcomeDoes HAP Reduce Dental Caries?
Kani [28]1989Apato 5% HAPKirara (HAP and F-free)181 children,
-3 years
Significant reduction in DMFT in the HAP groupyes
Lelli [29]2014Biorepair
(ZnCO3/n-HAP)
Sensodyne PronamelExtracted premolars after 8 weeks treatmentZinc-carbonated HAP showed better repair of damaged enamel than fluoride toothpasteyes
Makeeva [30]2016Apadent Total CareNo control30 subjects
-3 mo.
The long-term use of HAP toothpaste increases caries resistance of enamel yes
(but no control)
Schlagenhauf [31]2019Karex (10% HAP)1400 ppm fluoride toothpaste
(amine fluoride + SnF2)
150 subjects
-6 mo.
Works as well as fluoride paste in reducing caries (ICDAS) progressionyes
Bossù [32]2019Biorepair
(ZnCO3/n-HAP)
1. Ordinary toothpaste
2. 500 ppm fluoride toothpaste
3. 1400 ppm toothpaste
40 extracted primary teeth after 15 days trialZinc-carbonated HAP showed better remineralization properties than fluoride toothpasteyes
Badiee [33]20206.7% HAP toothpasteFluoride toothpaste50 post-orthodontic subjectsHAP toothpaste outperformed in fluoride toothpaste in caries reductionyes
Grocholewicz [34] 2020ApaCare Repair
(10% HAP gel)
(1) ozone
(2) not treatment
92 subjects
-2 years
HAP gel provided significant reversal of caries yes
Paszinska [35]2021Kinder Karex
(10% HAP)
Elmex Kinder Zahnpasta
(500 ppm F)
77 children
-1 year
HAP and fluoride toothpaste were equivalent in slowing caries progression (ICDASyes
Verma [36]2021Apagard Premio Toothpaste
(10% HAP)
Amflor toothpaste (amine fluoride)30 orthodontic subjects
-15 days
The HAP toothpaste was superior to fluoride toothpaste in restoring the enamel surface post-orthodontic bondingyes
Butera [37]2021MicroRepair (ZnCO3/n-HAP)Sensodyne Repair and Protect20 subjects with orthodontic buttons
-30 days
More deposition of Phosphate and Calcium on the composite resin in the HAP grouplikely
Butera [38]2022Biorepair Total Protective RepairSame toothpaste + ZnCO3/n-HAP mouthwash40 rugby players
-90 days
Erosion index improved in both test and controllikely
Paszynska [39]202310% HAPNaF toothpaste (1450 ppm fluoride)171 adults
-18 months
HAP toothpaste was equivalent to fluoride toothpaste in preventing new caries lesions as measured by DMFS and DIAGNOcamyes
(b)
Study First AuthorYearTest
(HAP Used)
ControlsTrial Subjects,
Duration
OutcomeDoes HAP Remineralize Human Enamel?
Najibfarb [40]2011Apagard
(5% HAP or 10% HAP)
Crest fluoride toothpaste30 subjects
-28 days per phase
10% hydroxyapatite tooth-paste caused remineralization comparable to a fluoride den-tifrice, inhibiting in situ caries development as effectively as fluoride toothpasteyes
Amaechi [41]2019Karex (10% HAP)Elmex
(Amine fluoride toothpaste,
500 ppm F)
32 subjects wearing appliances with imbedded human enamel blocks
-2 mo. (with crossover)
The HAP toothpaste works as well as the fluoride toothpaste in remineralizing enamelyes
Amaechi [42]2021Apagard Deep Care (5% nHAP) along with Apagard M-plus (5% nHAP)Placebo along with Apagard M-Plus
(5% n-HAP)
32 subjects wearing appliances with imbedded human enamel blocks
-2 mo. (with crossover)
5% HAP toothpaste remineralized enamel and the added 5% HAP lotion improved the remineralizationyes
Amaechi [43]2022Bioniq Repair-Zahncreme (20% HAP)Colgate Komplett 8 Zahnpaste
(1450 ppm F)
15 subjects wearing appliances with imbedded human enamel blocks
-1 mo. (with crossover)
HAP toothpaste achieved significantly higher remineralization of MIH lesions than the fluoride toothpasteyes
(c)
Study First AuthorYearTest
(HAP Product Used)
ControlsTrial Subjects,
Duration
OutcomeDoes HAP Toothpaste
Desensitize Teeth?
Hüttemann [44]198717% HAP
A: with 6 µm particles
B: with 2 µm particles
B: 17% salt, C: 0.125% benzocaine, D: placebo, E: 9% HAP. 8% salt, 0.125% benzocaine, F: 17% HAP, 6% SrCl2, G: 17% HAP, 5% SrCl2, 1% amine fluoride140 adults
-2 weeks
HAP reduced DH over controlsyes
Barone [45]199115% HAP pasteno treatment control40 adults
-24 weeks
reduced DH in the HAP groupbased on before and after measurementsmaybe
Park [46]2005HAP toothpasteno treatment control44 adults
-8 weeks
the HAP toothpaste reduced DHmaybe
Kim [47]2008Diome Plus PRTC
(10% HAP) toothpaste
Strontium chloride toothpaste (Sensodyne GSK)100 adults
-4 weeks
HAP toothpaste worked as well as strontium toothpaste to lower DHyes
Kang [48]2009Diome Plus PRTC
(10% HAP) toothpaste
Fluoride toothpaste (2080 Korea)
Strontium chloride toothpaste (Sensodyne GSK)
150 adults
-4 weeks
HAP toothpaste reduced DHyes
Kim [49]2009Diome Plus PRTC
(10% HAP) toothpaste
Strontium chloride toothpaste (Sensodyne GSK)55 adults
-8 weeks
HAP toothpaste worked as well as strontium toothpaste to lower DHyes
Orsini [50]2010Biorepair Plus
(30% Zn-carbonate HAP)
Sensodyne Pronamel75 adults
-8 weeks
Zn-Carbonated HAP toothpaste reduced DHyes
Shetty [51]2010A: HAP in dry sol powder
B: HAP liquid
C: placebo
D: no
treatment
45 adults
-8 weeks
the HAP toothpaste reduced DH more that the controlsyes
Browning [52]2012Renamel nHAP toothpasteplacebo42 adults
-2 weeks
HAP toothpaste reduced DHyes
Orsini [53]2013Biorepair Plus
(30% Zn-carbonate HAP)
Colgate Sensitive
(8% arginine, MFP at 1450 ppm fluoride)
Sensodyne Rapid Relief
(8% strontium acetate, NaF at 1044 ppm fluoride)
90 adults
-3 days
all three toothpastes reduced DH equallyyes
Jena [54]2015NanoXIM
(15% HAP)
Vantej (5% Novamin)
Sensitive Pro-Relief
45 adults
-4 weeks
HAP toothpaste was more effective than 5% Novamin toothpasteyes
Pinojj [55]2014HAP toothpaste (SHY NM)CSPS toothpaste (SHY)
CPP-ACP
80 teeth (adult subjects)
-3 months
the HAP and CSPS toothpastes worked better to reduce DH than the CPP-ACP pasteyes
Reddy [56]2014Acclaim
(15% HAP)
Colgate ProArgin30 adults
3 days
both toothpastes (HAP and arginine) reduced DHyes
Vano [57]2014Prevdent
(15% HAP)
Colgate Cavity Protection (1500 ppm fluoride in MFP)
Placebo
105 adults
-4 weeks
the HAP toothpaste worked better than the fluoride toothpaste to reduce DHyes
VJ Narmantha [58]2014Acclaim
(1% HAP)
Sensodent-K (5% KNO3)
Propolis
45 adults
-4 weeks
HAP toothpaste and Propolis toothpaste both reduced DHyes
Amin [59]2015Acclaim
(15% HAP)
none30 adults
-6 mo.
HAP toothpaste reduced DHmaybe
Gopinath [60]2015Acclaim
(10% nHAP)
Shy-NM (5% CSPS)36 adults
-4 weeks
both HAP and CSPS toothpastes lowered DHyes
Lee [61]2015Denti-guard Sensitive
(20% Carbonated HAP, 8% silica)
Sensodyne (10% CaCO3, 10% Strontium chloride)
Laser treatment
82 adults
-4 weeks
HAP toothpaste worked as well as strontium chloride toothpaste and professional laser treatmentyes
Vano [62]2015Prevdent
(2% HAP in 6% hydrogen peroxide toothpaste)
6% hydrogen peroxide toothpaste control60 subjects
-2 weeks
the HAP added to peroxide toothpaste reduced DHyes
Makeeva [30]2016Apadent Total Care
(10% HAP)
No treatment control30 adults
-3 months
HAP toothpaste reduced DHmaybe
Anand [63]20171% nHAP toothpastePro-Argin sensitivity fluoride toothpaste60 adults
-4 weeks
both nHAP and Pro-Argin reduce DHyes
Makeeva [64]2018Innova paste
(6% Nano-HAP) +
Liquid Enamel
(1% Nano-HAP liquid)
No treatment control40 adults
-2 weeks
The combination of HAP toothpaste and HAP mouthwash reduced DHmaybe
Amaechi [65]2018Apadent Pro dental cream (20% HAP)20% silica cream52 adults
-8 weeks
HAP-group showed reduced DH compared to silicayes
Vano [66]2018Cavex Bite & White ExSense
(2% nHAP toothpaste)
Colgate Cavity Protection Gel
placebo
105 adults
-4 weeks
HAP toothpaste reduced DH more than the placeboyes
Al Asmari [67]2019Biorepair
(20% Zn-carbonate hydroxyapatite)
no treatment control72 adults
-8 weeks
reduced DHmaybe
Kondyurova [68]2019SPLAT Sensitive Ultra (0.5% nHAP)0.1% nHAP (Splat Professional Sensitive White)60 adults
-4 weeks
both concentrations of HAP reduced DHyes
Alancar [69]2020nHAP toothpaste (± laser)Placebo + laser
Placebo + simulated laser
32 adults
-1 mo.
HAP toothpaste reduced DH over controlyes
Ding [70]2020Dentiguard Sensitive
(20% nanocarbonate-apatite)
placebo45 adults
-6 weeks
HAP toothpaste reduced DH relative to controlyes
Alharith [71]2021Nano XIM toothpaste
(15% HAP)
Placebo
Fluorophat (5% NaF)
63 adults
-1 week
HAP toothpaste reduced DH better than fluorideyes
Amaechi [72]202110% and 15% nHAP toothpaste10% HAP + 5% KNO3
Na-MFP (1400 ppm F-) + CPSC
104 adults
-8 weeks
10% HAP ± KNO3 reduced DH and 15% HAP worked better than 10% HAPyes
Ehlers [73]2021Kinder Karex
(10% HAP)
Elmex Junior (amine fluoride at 1400 ppm fluoride)21 children
-8 weeks
HAP toothpaste worked as well as fluoride toothpaste in lowering DHyes
Polyakova [74]202220% HAP toothpasteZn-magnesium HAP
n-FAP toothpaste
30 adults
-1 month
the Zn-Magnesium HAP toothpaste worked better that the 20% HAP and n-FAP toothpasteyes
Vlasova [75]2022GARDA SILK (HAP toothpaste with Polyol Germanium Complex)fluoride toothpaste
no toothpaste control
120 adults
-2 weeks
HAP toothpaste with PGC reduced DH better than conventional fluoride toothpaste (no HAP-free PGC supplemented placebo used)maybe
Butera [76]2022Biorepair (30% Zn-HAP)-no treatment control25 MIH patients
-9 mo.
Zn-HAP showed desensitization of MIH teethyes
(d)
Study First AuthorYearTest
(HAP Product Used)
ControlsTrial Subjects,
Duration
OutcomeDoes HAP Toothpaste
Improve Gingival Health?
Harks [77]2016Zn-HAPpreviously used toothpaste46 adults
-4 weeks
subjective improvement of oral health in both groups (HAP and antibacterial toothpaste)maybe
Doroshina [78]2019Zn-carbonate HAP (CHA)CSPS toothpaste
Herbal toothpaste
25 adultsCHA did not perform as well as the CSPS and herbal toothpastes in reducing gingival health measurements (bleeding on probing)maybe
Monterubbianesi [79]2020Sensitive Ultra SplatBiorepair Gum Protection
Curaprox Enzycal Zero
no paste brushing control
80 adults
-14 days
all pastes improved gingival healthyes
Steinert [23]202020% Zn-HAPamine fluoride/stannous fluoride toothpaste46 subjects
-3 months
pocket depth, bleeding on probing improved with both toothpastesyes
Brauner [80]2022 the test toothpaste in combination of the mouthwash improved gingival healthnot shown directly
Andrea [81]2022Biorepair Peribiomaregular toothpaste (no preference)50 adults
-2 months
The HAP toothpaste improved gingival health parametersyes
(e)
Study First AuthorYearTest
(HAP Product Used)
ControlsTrial Subjects,
Duration
OutcomeDoes HAP Toothpaste
Whiten or Improve the Appearance of Teeth?
Niwa [82]20013% HAP toothpaste
15% HAP toothpaste
placebo toothpaste12 adults
-1 month
whitening of teeth was achieved (without polishing)yes
Raoufi [83]20100.1% HAP toothpastecalcium peroxide toothpaste
placebo toothpaste
150 adults
-3 months
unable to demonstrate tooth whitening (HAP concentration was too low)no, concentration was too low
Woo [84]20140.25% HAP toothpaste0.075% Hydrogen peroxide
placebo toothpaste
85 adults
-3 months
hydrogen peroxide whitening teeth more than HAP toothpastemaybe, even at a very low concentration
Bommer [85]2018self-assembling peptide matrix and HAPno treatment control40 adults
-1 month
whitening based on diffuse reflection in vitro was seen in vivoyes
Steinert [86]2020HAP gel 25 adults
-1 month
subjective whitening of teeth was achieved by HAPyes
Steinert [23]202020% Zn-HAP 46 subjects
-1 month
patients reported smoother, whiter teeth when using HAPyes
WSL: white spot lesion; HAP: hydroxyapatite; nHAP: nano-hydroxyapatite; F: fluoride; ICDAS: international caries detection and assessment system; DH: dentin hypersensitivity.
Table 2. (a) Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) clinical trials on reducing caries or white spot lesions (WSL) or preventing erosion, listed chronologically. (b) Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) studies in situ using human enamel to measure remineralization or erosion resistance, listed chronologically. (c) Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) clinical trials on reducing dentin hypersensitivity listed chronologically. (d) Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) clinical trials on improvement of gingival health. (e) Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) clinical trials on improving tooth appearance.
Table 2. (a) Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) clinical trials on reducing caries or white spot lesions (WSL) or preventing erosion, listed chronologically. (b) Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) studies in situ using human enamel to measure remineralization or erosion resistance, listed chronologically. (c) Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) clinical trials on reducing dentin hypersensitivity listed chronologically. (d) Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) clinical trials on improvement of gingival health. (e) Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) clinical trials on improving tooth appearance.
(a)
Study First AuthorYearTest
(CPP-ACP Used)
ControlsTrial Subjects,
Duration
OutcomeDoes F-Free CPP-ACP Clinically
Reverse WSLs?
Andersson [87]2007Topacal
1st 3 mo.
0.05% NaF rinse + brushing with F toothpaste26 adolescents
-12 mo.
CPP-ACP = 63% complete visual loss of WSL compared to 25% with Fyes
Bailey [88]2009CPP-ACP in addition to regular F toothpaste usePlacebo in addition to regular F toothpaste use45 teens
-3 mo.
CPP-ACP = 31% more regression of ICDAS II scores than placeboyes
Rao [89]20092% CPP(1) 0.76% Na MFP
(2) placebo paste
150 children
-24 mo
Both CPP and MFP significantly but equally reduced caries increment compared to placeboyes
Uysal [90]2010Tooth Mousse(1) Fluoridin N5
(2) placebo
21 orthodontic volunteers
donated 60 teeth after 2 mo. trial
Both test groups successfully inhibited caries better than controlsyes
Bröchner [91]2011Tooth Mousse in addition to regular F toothpaste usePearl Powder gel in addition to regular F toothpaste use30 subjects,
-12 mo.
Reduction in QLF for WSL for both test and controlyes
Akin [92]2012Tooth Mousse(1) brush
(2) 0.025% F rinse
80 subjects,
-6 mo.
CPP-ACP = 58% reduction in WSL area
(1) 45%, (2) 48% (3) micro-abrasion 97%
yes
Sitthisettapong [93]201210% CPP-ACP in addition to regular F toothpaste useRegular toothbrushing with a F paste296 preschoolers
-12 mo.
ICDAS scores were no difference between test and controlno
Wang [94]2012Tooth Mousse 1100 ppm F paste20 orthodontic patients
-6 mo.
CPP-ACP significantly reduced WSL as measured by enamel decalcification index- the F paste control did notyes
Krithikadatta [95]201310% CPP-ACP(1) MI Paste plus 0.2% NaF
(2) 0.5% NaF mouth rinse
45 subjects
-1 mo.
Both CPP-ACP groups had fewer WSL (visual) with decrease in DIAGNOdent readings compared to the control yes
Plonka [96]201310% CPP-ACP along with 0.304% F paste0.12% Chlorhexidine (CHX) along with 0.304% F paste622 children
-24 mo.
No significant caries increment benefit over fluoride for CPP-ACP or CHXno
Aykut-
Yetkiner [97]
2014Tooth MousseF toothpaste60 children
-3 mo.
CPP-ACP provided a slight remineralization effect as measured by DIAGNOdent compared to F pasteyes
Yazıcıoğlu [98]2014Tooth Mousse(1) no treatment
(2) ozone
(3) APF gel
(4) Clearfil Protect Bond
125 approximal lesions
-18 mo
All groups arrested approximal lesions compared to the non-treatment groupyes
Zhang [99]2014CPP-ACPFluoride varnish (Duraphat)112 head cancer patients
-12 mo
CPP-ACP reduced radiation caries more than FVyes
Llena [100]2015CPP-ACP(1) CPP-ACFP
(2) fluoride varnish (FV) monthly
786 WSLs in children
3 mo.
CPP-ACP reduced DIAGNOdent and ICDASII scores, but CPP-ACFP and FV were superioryes
Memarpour [101]2015Tooth Mousse(1) OHI, dietary counseling
(2) (1) + fluoride varnish (FV)
(3) no treatment
140 children
-12 mo.
CPP-ACP reduced the size of WSL and produced smaller increases of dmft scores compared to counselling and FV yes
Sitthisettapong [102]201510% CPP-ACP in addition to regular F toothpaste useRegular toothbrushing with a F paste103 children
-12 mo.
There was significant reduction in QFL but no significant difference between test and controlno
Sim [103]2019CPP-ACP along with 0.4% SnF2 + 0.32% NaF pastePlacebo24 head and neck cancer patients
-3 mo.
The test subjects had a 51% reduction in caries as measured by ICDASIIyes
Esenlik [104]2016Tooth MousseNo other treatment57 patients
-12 mo.
CPP-ACP significantly reduced WSLs yes
Güçlü [105]2016CPP-ACP(1) 5% NaF varnish (FV)
(2) FV + CPP-ACP
(3) no treatment
21 children
-3 mo.
Control FV< CPP-ACP or CPP-ACP + FV in laser fluorescent and visual assessment of WSLsyes
Munjal [106]2016Tooth Mousse No treatment, no orthodontics679 WSLs
(20 treatment group children)
-3 mo.
CPP-ACP significantly reduced the WSLs compared to controls according to computerized image analysisyes
Singh [107]201610% CPP-ACP in addition to regular F toothpaste use(1) Fluoride varnish in addition to regular toothpaste use
(2)regular fluoride toothpaste use
45 subjects post orthodontics
-6 mo.
Both FV and CPP-ACP were more effective than F-toothpaste in reducing WSLs (visual, DIAGNOdent readings)yes
Karabekiroğlu [108]201710% CPP-ACPF toothpaste41 subjects
-36 mo.
CPP-ACP was not better than regular F paste in reducing WSLs as measured by DIAGNOdent, Gorelik index, ICDAS IIno
Mendes [109]2018CPP-ACP(1) CPP-ACP + fluoride
(2) F gel
(3) placebo paste
36 children
-3 mo.
All treatments produced decreased DIAGNOdent readings, with the best result obtained with CPP-ACP + Fyes
Wang [110]2018Tooth Mousse in addition to regular F toothpaste use(1) F paste + 0.01% F mouth rinse
(2) F paste only
21 orthodontic patients
-6 mo.
WSL areas were reduced in all groups and the CPP-ACP had the greatest effectyes
Bobu [111]201910% CPP-ACP(1) CPP-ACFP
(2) 2–10% CPP-ACP + 0.2% NaF paste
(3) 0.05% NaF mouth rinse
(4) control
80 subjects
-3 mo.
All treatment groups significantly lowered DIAGNOdent readings and visual appearance of early caries lesionsyes
Tingyun [112]2019MI Paste(1) F-free placebo
(2) OHOLV toothpaste
15 orthodontic patients donated 60 premolars after 10-day treatmentCPP-ACP and OHOLV produced higher calcium and phosphate levels in demineralized enamelyes
Al-Batayneh [113]2020Tooth Mousse(1) 500 ppm F toothpaste
(2) 1 + Tooth Mousse
114 children
-6 mo.
CPP-ACP = fluoride paste in reducing QFL, WSL area
-CPP-ACP not a booster for F paste)
yes
Bangi [114]2020Tooth Mousse(1) Colgate Strong toothpaste
(2) Colgate Phos-Flur mouthwash
(3) SHY-NM (CSPS glass paste)
80 subjects,
-6 mo.
All significantly reduced WSL decalcification index, but CPP-ACP outperformed the others yes
Perić [115]2020CPP-ACP(1) CPP-ACFP
(2) 0.05% NaF mouth rinse
30 Sjögren’s patients
-6 mo
Reduction in WSL in all groups, but no significant difference in DMFSyes
Ashour [116]2021Tooth Mousse in addition to regular F toothpaste use(1) Tooth Mousse Plus + F toothpaste
(2) F toothpaste only
51 subjects
-6 mo.
All treatment groups provided slight remineralization as judged by Vistacam scores yes
Juárez-López [117]2021CPP-ACP in addition to regular F toothpaste use(1) Chewing gum with CPP-ACP
(2) F toothpaste only
90 children
-3 mo.
CPP-ACP in chewing gum was more effective than CPP-ACP cream in decreasing fluorescenceyes
El-Sherif [118]2022CPP-ACPPearl powder57 subjects
-3 mo.
CPP-APP and pearl powder both reduced WSL areas and improved their color yes
Hamdi [119]2022CPP-ACP(1) SDF-KI
(2) tricalcium silicate (TCS)
45 patients
-24 mo.
Both CPP-ACP and TSC reduced DIAGNOdent readings. SDF-KI significantly remineralized early carious lesionsyes
Olgen [120]2022CPP-ACP(1)CPP-ACFP
(2) fluoride varnish (FV)
49 children with MIH
-24 mo.
All treatments significantly reduced DIAGNOdent and ICDAS scores with no significant difference between themyes
Salah [121]2022CPP-ACP(1) BiominF
(2) Novamin
60 orthodontic subjects
-6 mo.
ICDASII scores, WSL areas and DIAGNOdent scores were reduced by all treatments-BiominF was bestyes
Simon [122]2022Tooth MousseICON resin infiltration60 children
-12 mo.
Both treatments reduced WSL areas using ICDASII scores, digitized photosyes
(b)
Study First AuthorYearTest
(CPP-ACP Product Used)
ControlsStudy DesignOutcomeDoes F-Free CPP-ACP
Remin-
eralize Human Enamel?
Srinivasan [123]2010CPP-ACP(1) CPP-ACFP
(2) saliva placebo
5 volunteers wearing human enamel slabs imbedded in appliancesCPP-ACFP remineralized the enamel slabs better than CPP-ACP and both were substantially better than salivayes
Shen [124]2011Tooth Mousse (TM)(1) 1000 ppm F paste
(2) Clinpro with 950 ppm F
(3) 5000 ppm F paste
(4) Tooth Mousse + 900 ppm F (TMP)
(4) placebo
Volunteers wearing human enamel slabs in appliancesTMP was better than TM and both were better at remineralization than ClinproF or 5000 ppm F paste as measured by transverse microradiography yes
Perić [125]2015CPP-ACP(1) CPP-ACFP
(2) 0.05% NaF mouth rinse
30 Sjögren’s patients
-enamel slabs on appliances
1 mo.
Both CPP-ACP agents reduced enamel defects better than NaF mouthrinseyes
Garry [126]2017Tooth Mousse (along with F toothpaste)F toothpaste control12 patients wearing fixed orthodontic appliancesCPP-ACP significantly improved remineralization as measured by transverse microradiographyyes
Zawaideh [127]2017Tooth Mousse(1) Pronamel
(2) no treatment
20 subjects wearing appliances with human enamel slabs from permanent and primary teethCPP-ACP and fluoride protected against dental erosion as measured by surface microhardnessyes
Yu [128]2018Tooth MousseWater control12 volunteers wearing human enamel slabs in appliancesCPP-ACP reduced erosion as measured by microhardnessyes
de Oliveira [129]2020Mi Paste(1) MI Paste Plus
(2) 1000 ppm fluoride toothpaste
(3) placebo toothpaste
10 participants
-four 10-day experiments
Remineralizing agents (MP, MPP, and DF) were able to inhibit demineralization of human enamel subjected to high cariogenic challenge in situ. yes
de Oliveira [130]2022MI Paste(1) MI Paste Plus
(2) 1000 ppm fluoride toothpaste
(3) placebo toothpaste
10 participants
-four 10-day experiments
CPP-ACP and fluoride both prevent demineralization as measured by microhardnessyes
Kumar [131]2022CPP-ACPFluoride varnish (FV)30 subjects wearing ortho appliances with human MIH enamel slabs
-6 month
CPP-ACP = FV in remineralizing MIH enamelyes
(c)
Study First AuthorYearTest
(CPP-ACP Product Used)
ControlsStudy DesignOutcomeDoes F-Free CPP-ACP
reduce tooth sensitivity?
Borgess [132]2012CPP-ACPNo sensitivity treatment3 patients
-some teeth were treated with 20% carbamide peroxide with CPP-ACP
CPP-ACP reduce sensitivity compared to no treatment (pilot study)yes
Özgül [133]2013MI Paste(1) CPP-ACFP
(2) CPP-ACFP + ozone
(3) fluoride varnish (Bifluorid)
(4) FV + ozone
(5) CPP-ACP + ozone
42 MIH patients
-3 mo.
Ozone prolonged the desensitization effect of CPP-ACP and FV, but not CPP-ACFP
-all 3 effectively reduced tooth sensitivity
yes
Maghaireh [134]201410% CPP-ACP (1) 2% NaF gel
(2) placebo gel
51 patients after bleaching
-14 days
CPP-ACP can lower sensitivity post bleaching as well as Fyes
Mahesuti [135]2014MI Paste(1) UltraEZ (KNO3)
(2) UltraEZ placebo
(3) MI Paste placebo
102 subjects
-2 mo.
MI Paste has sustained pain relief compared to KNO3 yes
Zhang [136]2014CPP-ACPFluoride varnish (Duraphat)112 head and neck cancer patients
-12 mo
CPP-ACP reduced post radiation tooth sensitivity more than FVyes
Konekeri [137]2015CPP-ACP(2) KNO3 treatment48 patients
-6 weeks
CPP-ACP was better at reducing tooth sensitivity than KNO3yes
Nanjundasetty [138]2016Tooth Mousse(1) Sensodyne KF
(2) placebo
69 fluorosis patients
-10 min. after each bleaching session (2)
-7 days
MI Paste and Sensodyne equally reduced tooth sensitivity compared to the placeboyes
Tarique [139]2017CPP-ACP(1) 5% NaF varnish
(2) 5% KNO3
36 patients after bleaching
-10 day for 3 mo.
CPP-ACP effectively reduced tooth sensitivity more than the other two test groupsyes
Pasini [140]2018CPP-ACPF paste40 MIH patients
-3 mo.
CPP-ACP reduced tooth sensitivity compared to the F paste controlyes
Yassin [141]2019CPP-ACPPlacebo paste24 patients
-custom tray application 30 min/day, 7 days
after bleaching
CPP-ACP effectively reduced tooth sensitivity compared to the placebo pasteyes
Adil [142]2021CPP-ACP(1) KO3 + Na MFP
(2) placebo gel
2011 patients
-12 hr. for 3 days after bleaching
CPP-ACP and F effectively reduced tooth sensitivityyes
Gümüştaş [143]2022CPP-ACP (1) HAP
(2) NaF gel
64 subjects
-4 min application before bleaching
HAP and F treatments reduced sensitivity, CPP-ACP did notno
(d)
Study First AuthorYearTest
(CPP-ACP Product Used)
ControlsTrial Subjects,
Duration
OutcomeDoes CPP-ACP Toothpaste
Improve Gingival Health?
Perić [115]2020CPP-ACP toothpasteCPP-ACPP (with 0.5% NaF) toothpaste
0.5% NaF toothpaste
30 Sjögren’s patients
-4 weeks
no significant improvement in gingival health but improvement in dry mouth symptomsnot shown
(e)
No studies were found.
CPP-ACP: 10% casein phosphoprotein-amorphous calcium phosphate (MI Paste, Tooth Mousse); CPP-ACFP: 10% casein phosphoprotein-amorphous calcium phosphate with added fluoride to 900 ppm (MI Paste Plus, Tooth Mousse Plus); F: fluoride; FV: fluoride varnish; WSL: white spot lesion; QFL: quantitative fluorescent light; ICDAS II: international caries detection and assessment system (modified from ICDAS I).
Table 3. (a) Calcium sodium phosphosilicate (CSPS) clinical trials on reducing caries or white spot lesions (WSL) or preventing erosion, listed chronologically. (b) Calcium sodium phosphosilicate (CSPS) in situ clinical trials on reducing caries on preventing erosion. (c) Calcium sodium phosphosilicate (CSPS) clinical trials on reducing dentin hypersensitivity listed chronologically. (d) Calcium sodium phosphosilicate (CSPS) clinical trials on improvement of gingival health.
Table 3. (a) Calcium sodium phosphosilicate (CSPS) clinical trials on reducing caries or white spot lesions (WSL) or preventing erosion, listed chronologically. (b) Calcium sodium phosphosilicate (CSPS) in situ clinical trials on reducing caries on preventing erosion. (c) Calcium sodium phosphosilicate (CSPS) clinical trials on reducing dentin hypersensitivity listed chronologically. (d) Calcium sodium phosphosilicate (CSPS) clinical trials on improvement of gingival health.
(a)
Study First AuthorYearTest
(CSPS Used)
ControlsTrial Subjects,
Duration
OutcomeDoes CSPS Toothpaste Reduce Dental Caries?
Salah [121]2022Biomin slurry and toothpasteBiominF slurry and toothpaste
CPP-ACP toothpaste
60 orthodontic patients
-4 weeks
All three reduced WSL, with BiominF performing the bestyes
Tiwari [144]2023NovaMin toothpasteprobiotic toothpaste
fluoride toothpaste
93 orthodontic patients
-6 months
All three toothpastes reduced WSLs (the probiotic toothpaste group had the least WSLs)yes
(b)
No studies were found.
(c)
Study First AuthorYearTest
(CSPS Used)
ControlsTrial Subjects,
Duration
OutcomeDoes CSPS Toothpaste Desensitise Teeth
Du [145]2008NovaMin Toothpaste (2.5% and 7.5% CSPS)placebo toothpaste
Strontium chloride toothpaste
71 adults
-6 weeks
NovaMin reduced SDH better than placebo and strontium chloride toothpasteyes
Litkowski [146]2010NovaMin Toothpaste (2.5% and 7.5% CSPS)placebo toothpaste66 adults
-8 weeks
NovaMin reduced SDH better than placebo yes
Narongdej [147]2010NovaMin powder and toothpasteplacebo powder + NovaMin toothpaste
placebo powder + fluoride/KNO3 toothpaste
60 adults
-4 weeks
NovaMin powder and toothpaste reduced DH better than the Potassium nitrate/fluoride toothpasteyes
Pradeep [148]2010NovaMin toothpaste SHY-NM (5% CSPS)placebo
potassium nitrate toothpaste
110 adults
-6 weeks
NovaMin reduced DH better than the placebo and potassium nitrate toothpastesyes
Salian [149]2010NovaMin (5% CSPS)5% potassium nitrate toothpaste
placebo toothpaste
30 adults
-4 weeks
NovaMin reduced DH better than the placebo and potassium nitrate toothpastesyes
Sharma [150]2010NovaMin (7.5% CSPS)5% potassium nitrate toothpaste
0.4% Stannous fluoride toothpaste
120 subjects
-12 weeks
All three reduced DH but NovaMin worked better than the others at early time pointsyes
West [151]2011NovaMin (5% CSPS)8% arginine toothpaste
water control
placebo toothpaste
volunteers wore appliances with dentin slices
-4 days
NovaMin showed better dentin occlusion and retention than the arginine toothpasteyes
Pradeep [152]2012Novamin SHY (5% CSPS)5% potassium nitrate toothpaste
3.88% amine fluoride toothpaste
placebo toothpaste
149 adults
-6 weeks
The Novamin toothpaste showed better results than the others in lowering DHyes
Rajesh [153]2012Novamin SHY (5% CSPS)Pepsodent toothpaste30 adults
-8 weeks
NovaMin reduced DH better than the placebo toothpasteyes
Surve [154]2012CSPS toothpastepotassium nitrate toothpaste20 adults
-8 weeks
both reduced DHyes
Acharya [155]2013CSPS toothpastepotassium nitrate toothpaste20 adults
-8 weeks
both reduced DH but the CSPS toothpaste worked better early in the in the trialyes
Jena [54]2015Vantej (NovaMin 5% CSPS)Colgate Sensitive Pro-Relief -8% arginine with fluoride)
nanoXIM (15% HAP)
45 adults
-4 weeks
all three reduced DH, but nHAP toothpaste performed the bestyes
Pintado-Palomino [156]2015Bioglass 45S57.5% Biosilicate toothpaste
Sensodyne toothpaste
Odontis RX Sensi Block toothpaste
Desesibilize Nano P (HAP toothpaste
140 adults
-2 weeks
Toothpaste containing Bioactive glass reduced tooth sensitivity caused by vital bleachingyes
Samuel [157]2015NovaMin toothpasteProArgin toothpaste
Gluma Desensitizer
147 adults
-1 month
ProArgin toothpaste and Gluma sealer reduced DH from a single application compared to NovaMinyes
Majji [158]2016NovaMin (5% CSPS)5% potassium nitrate toothpaste
10% strontium chloride
herbal toothpaste
160 adults
-2 months
the CSPS toothpaste showed better reduction in DH than the othersyes
Sufi [159]20165% CSPSplacebo CSPS
fluoride toothpaste
134 adults
-8 weeks
small and inconsistent outcomesno
Sufi [160]20165% CSPSplacebo CSPS
fluoride toothpaste
134 adults
-8 weeks
CSPS paste reduced DH similar to placebono
Athurulu [161]20175% CSPS5% potassium nitrate toothpaste
3.85% Amine fluoride toothpaste
Placebo toothpaste
68 adults
-12 weeks
CSPS toothpaste was found to be more effective in reducing DH as the othersyes
Hall [162]20175% CSPS8% arginine/calcium carbonate toothpaste
regular fluoride toothpaste
133 adults
-11 weeks
CSPS and arginine toothpastes performed equally in reducing DHyes
Fu [163]20192.5% CSPS toothpaste8% arginine toothpaste
placebo toothpaste
147 adults
-8 weeks
the CSPS and qarginine toothpastes both equally reduced DH more than the controlyes
Alsherbiney [164]2020CSPS toothpaste Zn-carbonate nHAP toothpaste42 adults
-appliances worn with dentin slices
both toothpastes occluded dentin tubules but the HAP toothpaste provided immediate occlusion of dentin tubules
Bhowmik [165]2021NovaMin toothpaste SHY-NM (7.5% CSPS)Elgydium (fluorinol) toothpaste30 adults
-4 weeks
CSPS toothpaste reduced DH yes
Ongphichetmetha [166]20225% CSPS8% arginine45 adults
-2 weeks
SCPS and arginine toothpaste reduce DHyes
(d)
Study First AuthorYearTest
(CSPS Used)
ControlsTrial Subjects,
Duration
OutcomeDoes CSPS Toothpaste Improve Gingival Health?
Monterubbianesi [79]2020CSPS toothpasteHAP toothpaste
herbal toothpaste
25 adults
-2 weeks
CSPS toothpaste supported gingival health as well as the herbal toothpaste and better than the HAP toothpasteyes
Table 4. (a) Tricalcium phosphate (TCP) clinical trials on reducing caries or white spot lesions (WSL) or preventing erosion. (b) Tricalcium phosphate (TCP) in situ clinical trials on reducing caries on preventing erosion. (c) Tricalcium phosphate (TCP) clinical trials on reducing dentin hypersensitivity. (d) Tricalcium phosphate (TCP) clinical trials on improvement of gingival health. (e) TCP clinical trials on improving tooth appearance.
Table 4. (a) Tricalcium phosphate (TCP) clinical trials on reducing caries or white spot lesions (WSL) or preventing erosion. (b) Tricalcium phosphate (TCP) in situ clinical trials on reducing caries on preventing erosion. (c) Tricalcium phosphate (TCP) clinical trials on reducing dentin hypersensitivity. (d) Tricalcium phosphate (TCP) clinical trials on improvement of gingival health. (e) TCP clinical trials on improving tooth appearance.
(a)
Study First AuthorYearTest
(TCP Used)
ControlsTrial Subjects,
Duration
OutcomeDoes TCP Toothpaste Reduce Dental Caries?
Detsomboonrat [167]2016Pureen 1000 ppm fluoride toothpaste
500 ppm fluoride toothpaste
131 mother-child dyads
-1 year
caries were reduced by the TCP toothpaste as well as the fluoride toothpastesyes
(b)
No studies were found.
(c)
Study First AuthorYearTest
(CSPS Product Used)
ControlsTrial Subjects,
Duration
OutcomeDoes TCP Toothpaste
Desensitize Teeth?
Jang [168]2023Vussen S (190% TCP)Sensodyne
Pleasia (fluoride free)
53 adults
-4 weeks
TCP toothpaste effectively reduces DH better than placeboyes
(d)
No studies were found.
(e)
No studies were found.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Limeback, H.; Enax, J.; Meyer, F. Improving Oral Health with Fluoride-Free Calcium-Phosphate-Based Biomimetic Toothpastes: An Update of the Clinical Evidence. Biomimetics 2023, 8, 331. https://doi.org/10.3390/biomimetics8040331

AMA Style

Limeback H, Enax J, Meyer F. Improving Oral Health with Fluoride-Free Calcium-Phosphate-Based Biomimetic Toothpastes: An Update of the Clinical Evidence. Biomimetics. 2023; 8(4):331. https://doi.org/10.3390/biomimetics8040331

Chicago/Turabian Style

Limeback, Hardy, Joachim Enax, and Frederic Meyer. 2023. "Improving Oral Health with Fluoride-Free Calcium-Phosphate-Based Biomimetic Toothpastes: An Update of the Clinical Evidence" Biomimetics 8, no. 4: 331. https://doi.org/10.3390/biomimetics8040331

APA Style

Limeback, H., Enax, J., & Meyer, F. (2023). Improving Oral Health with Fluoride-Free Calcium-Phosphate-Based Biomimetic Toothpastes: An Update of the Clinical Evidence. Biomimetics, 8(4), 331. https://doi.org/10.3390/biomimetics8040331

Article Metrics

Back to TopTop